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Abstract
There is a considerable interest in new technologies that allow noninvasive imaging of
physiological parameters in living systems, especially in the neuroscience. Magnetic
resonance imaging (MRI) is a very powerful tool for neuroimaging, because it can image
the tissue noninvasively, in depth, at a good spatial (~100 pm) and temporal (~1s)
resolution. In order to study neural activity at a cellular level, it would be of notable
significance to combine MRI with calcium-sensitive contrast agents because of the
important role of calcium as a second messenger in cellular signaling pathways. Here we
describe a family of calcium sensors for MRI based on the conjugation of
superparamagnetic iron oxide nanoparticles (SPIOS) to calcium sensing protein
calmodulin and its target peptides. In the presence of calcium, interaction between the
two protein domains drives the aggregation of SPIOs which results in up to four fold T2
changes. The calcium sensing is reversible and occurs at midpoint of roughly 1 ptM Ca ,
which makes these contrast agents suitable for imaging of the cytosolic calcium
fluctuations in cells. We introduce two generations of these sensors: the first one based
on commercial larger SPIOs, and the second one that uses small crosslinked lipid coated
nanoparticles (xLCIOs) which have potential to overcome some of the limitations of the
prototype sensor, such as inadequate diffusivity and relatively slow kinetic response.
When combined with technologies for cellular deliveries of nanoparticles, these sensors
and their derivatives may be useful for functional molecular imaging of biological
signaling network in live, opaque specimens.
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1. Background and Introduction
1.1 Molecular imaging: motivation and modalities
Molecular imaging is a rapidly growing field of biomedical research that is focused
on understanding biological phenomena on a molecular level. This growing scientific
discipline aims to develop novel tools and methods to image specific molecular pathways
in vivo (1).
Neuroscience is a research discipline that can especially benefit from development
of molecular imaging technologies. A fundamental goal in this area is to gain a better
understanding of the function of the neural circuits and signaling events in the brain.
Electrophysiology is a standard method to study neuronal activity by using microelec-
trodes to record the action potentials of individual neurons. This approach is invasive
and can not record from the whole brain at once. On the other hand, information on a
cellular level has historically been only available from in vitro assays, from the studies of
cells or fixed tissues, which lead to information loss compared to studies in live speci-
mens. Recently, various molecular probes have been developed to study molecular
events in real time, using imaging modalities such as optical imaging, positron emission
tomography (PET), and magnetic resonance imaging (MRI). Lately, probes that can be
used in multi-modal imaging are being developed as well.
Optical imaging sensors are typically based on fluorescence or bioluminescence. A
variety of fluorescent sensors has been developed to target enzyme activity, pH, DNA
and RNA interactions, metal ions and various metabolites (2-4), which have great sensi-
tivity as well as spatial (< 1 pim) and temporal (1ims) resolution. However, these meth-
ods can only be applied to cells or surface tissues because of the tissue scattering of the
light. This presents a particular issue for neuroscience studies, because the skull encasing
the brain is opaque.
PET is based on the detection of y-photons produced from radioactive, positron-
emitting probes after positron-electron annihilation. The most widely used PET probe is
18F-fluorodeoxyglucose (FDG), which accumulates in the areas of increased metabolic
activity, such as tumors (5). Other PET sensors have been developed to study the expres-
sion and spatial distribution of receptor ligands (6). PET has exquisite sensitivity; it can
detect the probes in picomolar range. Another advantage of PET as that it can be per-
formed in a quantitative way. This method has a couple of limitations when it comes to
molecular imaging: the spatial resolution is very low (1 mm or worse), the signal is al-
ways "on" so it can not be made sensitive to a particular molecular event as it is happen-
ing, and the data interpretation is often based on kinetic modeling.
Magnetic resonance imaging (MRI) is a very powerful tool for neuroimaging, be-
cause it can be done in vivo, deep into the tissue, with good resolution. Most of the func-
tional MRI imaging is based on the blood oxygenation level dependence (BOLD) effect,
which is a combination of changes in local blood oxygenation, flow and volume triggered
by elevated neural activity. BOLD offers a noninvasive, though indirect readout of re-
gional brain activity (7, 8). The resolution and specificity of this conventional fMRI
technique are seriously limited by hemodynamics. A number of strategies have been
proposed to sensitize MRI signal to the cellular level neuronal activity. The most promis-
ing one may be the use of image-altering chemicals, called contrast agents, which change
the pattern of distribution of signal intensity in an MRI image. A variety of mechanisms
are available by which MRI contrast agents can produce a change in image contrast as a
response to interaction with a specific target. The physical origin of the signal in MR and
the MRI contrast agents are discussed in the next couple of sections.
1.2 Principles of nuclear magnetic resonance (NMR)
Nuclear Magnetic Resonance is a physical phenomenon that was detected for the
first time in 1946 by Bloch (9, 10) and Purcell (11) independently, for which they shared
a Nobel Prize in physics 6 years later. NMR is concerned with the interaction of the nu-
clear spin angular momentum of the sample, placed in static magnetic field, and an oscil-
lating electromagnetic field (the radio frequency field). The theory of NMR can be de-
.1
scribed using both quantum-mechanical and classical way for spin - nuclei. Both will2
be utilized here in this introduction.
Only isotopes with non-zero angular momentum can be observed by NMR. Such
nuclei must have an odd number of protons or neutrons, and most commonly used ones
for NMR are H, H, 13C, 19F, 31P etc. Nuclei with non-zero spin angular momentum, I,
have an associated magnetic momentum, p, which are related by gyromagnetic ratio:
p = yAI
For spin - nuclei, the nuclear charge distribution is spherically symmetric, so the
2
nucleus then has the properties of a magnetic dipole whose strength is described by the
above equation. Nuclei with spin - are most often studied by NMR. The most widely
2
studied nucleus is by far that of hydrogen 'H, which has greatest importance.
The energy of a nuclear magnetic dipole in an external magnetic field is given by
the classical expression as:
E =-eBO
where BO is the strength of the external magnetic field. In NMR the typical system is the
one where the applied magnetic field is oriented along the z-axis. Hydrogen can basi-
cally have two different energy levels in the field, which correspond to the magnetic
moment oriented along or against the external field. The signal that is measured in NMR
is the result of the transition between those two energy levels, and the energy difference
is dependent on the magnetic field strength:
AE = hyBo = hco
The resonance frequency is referred to as the Larmor frequency, OL:
SL 
=7BO
In thermal equilibrium, the relative populations of spins in the two states (parallel
and antiparallel to the field) are in accordance with Boltzman statistics:
N AE 40_
__=_ kBT =e kBT
N.,
At room temperature, the polarization is only about one part in a million. It is this excess
polarization that leads to the NMR signal. The aligned nuclear magnetic moments, total
number of which is denoted by N, provide a bulk magnetization to the sample which can
be expressed as:
N7 2 h2B0M1 ~
4kBT
The dynamics of this magnetization in a magnetic field can be described by two types of
motion (12):
1. The rotation of the magnetization about an applied magnetic field, or Larmor pre-
cession, for which the classical torque equation applies:
dM
-= M x B
dt
2. A damping or relaxation behavior that drives the system back to the equilibrium.
If the bulk magnetization is along the field direction, there is no torque and hence
no motion, as it is at equilibrium. If the system is away from the equilibrium state, that
is, if the bulk magnetization vector is not oriented along the z-axis, then the magnetiza-
tion vector precesses around the z-axis with the angular frequency equal to Larmor fre-
quency, and there is also a relaxation process to bring the vector back to along the z-axis.
The x- and y- components of the magnetization decay towards zero, and the z-component
decays to the equilibrium value of Mo. The complete spin dynamics is described by the
Bloch equations, which in the rotating frame, with a field rotating along the x-axis are
given by:
dMX M
dt T2
dM ~M,d = AcoM, + OM T
d~t T2
dM 1
=z-co My - (M - MO)
d~t T,
where Ao is a small off-resonance term, the difference between the rotating frame fre-
quency and the Larmor frequency, and oi is the strength of the rotating field (radio fre-
quency field), given with yB1. The time constants that appear in these equations describe
the relaxation of the system back to the equilibrium. T, is the spin-lattice relaxation con-
stant or longitudinal relaxation time. T2 is the spin-spin relaxation constant or transverse
relaxation time. These constants are phenomenlogically introduced into Bloch equations.
1.3 Relaxation in NMR
The equilibrium state of a spin system in a static magnetic field has two important
features: there is a magnetization parallel to the applied field and there is zero magnetiza-
tion in the plane perpendicular to the field (13). Once the system is perturbed with the
application of the radio frequency (rf) pulses, it returns to thermal equilibrium. The
physical cause of relaxation lies in the fact that not all the nuclei see exactly the same
magnetic field, and moreover, these fields may change with time. The system does this
through two types of relaxation processes, longitudinal and transverse, which are charac-
terized by time constants Ti and T2, respectively. Longitudinal relaxation is the return of
the z-component of the magnetization to the equilibrium value, Mo. Immediately follow-
ing the 900 rf pulse, the z-component of the magnetization is zero, and as time elapses, it
increases exponentially until the equilibrium value is restored:
t
M,(t)= Mo(1-e Ti)
Transverse relaxation involves the dephasing of the magnetization on the x-y plane.
There are two main reasons for this net loss of coherence. A time constant T2 is used to
describe the transverse relaxation due to processes that are intrinsic to the sample, such as
dipolar interaction between the proton spins. However, there are other, external causes of
the transverse relaxation, such as the inhomogeneity of the static field Bo, and the combi-
nation of all of these contributions is described with the time constant T2*. Right after the
90' rf pulse, the transverse components of the magnetization will have the same ampli-
tude as MO and with time will exponentially decay to zero with time constant T2*:
t
Ml,(t)=Moe T2
In NMR, relaxation of the magnetization back to the thermal equilibrium state is
1.
caused by the fluctuating local magnetic fields. Spin - is treated as magnetic dipole.
2
Since molecules are continually moving (translating, rotating, vibrating etc.), these mo-
tions modulate the interactions between the nuclei. Therefore, molecular motions can
cause the local fields to fluctuate and allow the spins to relax via some interaction, such
as dipolar interaction Spins can also relax via other mechanisms too, such as chemical
shift anisotropy, scalar coupling and spin-rotation interactions.
From the equation of motion of magnetization in a magnetic field, one can conclude
that change of the local fields in z-direction has no effect on T1, only on T2. Thus, Ti
depends only on changes of local magnetic fields in the transverse plane, which are af-
fected by fast molecular motions. T2 is affected by both fast and slow molecular motions.
This is a very important difference between T1 and T2 . T2 is always to shorter or equal to
T1 because of the cylindrical symmetry of the Hamiltonian that describes these processes.
In order to look at the molecular motions in more detail, the concepts of correlation
function and correlation times will be introduced. The correlation function describes the
average behavior of a molecular motion in a system and is typically defined the correla-
tion between random variables at two different points in space or time. If one considers
the correlation function between random variables at the same point but at two different
times then one refers to this as the autocorrelation function. It can usually be approxi-
mated by an exponential function:
G(t)= A2e ,
It has a characteristic time scale defined by the correlation time rc. This time is related to
the variations of the local magnetic fields. For times much smaller than uc correlation
function varies negligibly from its initial value, while for times significantly greater than
,c G(t) has decayed to zero. The Fourier transform of the correlation function is called
spectral density function and it describes the range of frequencies at which the motion
exists. If G(t) is described by an exponential function as above, than the spectral density
function is Lorentzian:
J(co) oc A 2 2 21+ rc
1
The spectral density maximum occurs when rc = -, which is another way of stating that
CO)
efficient relaxation in NMR occurs when a motion has frequency components at the Lar-
mor frequency. Experimentally, if we wish to increase the correlation time (slow down
the system) one approach to do so would be to increase the viscosity of the solution by
lowering the temperature. Conversely, increasing the temperature will speed up the sys-
tem (lower the correlation time).
The primary interaction that is responsible for the relaxation in the proton systems
is the dipolar interaction. Using the expression for the dipolar Hamiltonian for the inter-
action between two spins, the relaxation rates are:
1 y4
- OC' [J(coo) + J(2wo)]
T r 6
1 y4
-- c -[J(O) + J(coo) + J(2coo)]
T2 r
The spectral density functions indicate the magnitude of a frequency component at a
specified frequency. T1 relaxation depends on frequency components at Larmor fre-
quency and twice that value - fast dynamic processes. T2 has the same terms with the
addition of the zero frequency term, which corresponds to slow dynamic processes.
The intrinsic T2 relaxation time is usually measured by a spin-echo type pulse se-
quence, which consists of a 900 pulse followed by a 1800 pulse after a suitable time delay
,c . One can do several such experiments and vary the time delay, or the whole experi-
ment can be done in one shot using multiple 1800 pulses. T2 can be extracted from the
plot of the amplitudes of the echo signals vs. time, by the equation:
T
M4, (r) = Moe T
The most common way to measure T, relaxation time is the inversion recovery pulse
sequence. It a contains a 1800 pulse, and a delay of some time 'U, followed by a 900 pulse.
If the experiment is repeated a couple of times using different delay times, T1 can than be
determined using the equation:
M,(r) = MO (1-2e )
1.4 Relaxation in the presence of contrast agents
Contrast agents for MRI are image-altering chemicals that modify patterns of con-
trast in an MRI image, rather than being imaged directly. Most of the MRI contrast
agents are paramagnetic substances whose large paramagnetic moment interacts with
water spins that are being imaged, promoting their relaxation (Figure 1A, B). They
shorten the longitudinal relaxation time TI, or the transverse relaxation time T2 ; this re-
sults in image brightening in case of the Ti agents and image darkening in case of the T2
agents. T, contrast agents are typically complexes of paramagnetic metal ions, such as
Gd"3 , whose unpaired electrons interact with the water spins. The most commonly used
T2 contrast agents are superparamagnetic iron oxide nanoparticles (SPIOs), which consist
of the iron oxide core and a coating that makes them water soluble. They produce local
magnetic field inhomogeneities, which promote the transverse relaxation of the water
protons. There are other types of contrast agents which work through different mecha-
nisms, such as chemical exchange saturation transfer (CEST) contrast agents (14). A
CEST contrast agent contains labile protons that exchange with bulk water, but have well
resolved chemical shifts.. If the exchangeable protons are presaturated using an appro-
priate rf pulse, the signal of the bulk water pool is reduced since these protons are ex-
changing with the presaturated ones. This produces darkening in the MRI image. CEST
contrast may be turned on and off, since it is dependent on the power and frequency of
the presaturation rf pulse (Figure 1 C). Another way to produce MRI contrast is by imag-
ing non-standard nuclei, such as 13C (15). The images are formed in an equivalent man-
ner to the proton imaging, but usually result in much lower signal-to-noise ratio. One of
the ways to improve the MRI signal of 13 C containing molecules is to hyperpolarize them
right before the imaging using techniques such as dynamic nuclear polarization (Figure
ID).
In the presence of the relaxation promoting contrast agents, the observed relaxation
rate will be the sum of the diamagnetic and paramagnetic contributions, given by:
( )ob= (I )d +() i = 1, 2
The diamagnetic contribution represents the relaxation rate of the solvent in the absence
of the paramagnetic species. In the absence of the solute-solute interactions, a simple
model for the dependence of the paramagnetic relaxation rate on the concentration of the
paramagnetic species [C] is a linear one. Relaxivity (Ri) is the slope of this dependence,
defined in the units of s-1 M-1 (more commonly s-1 mM') and it represents the strength of
a contrast agent.
()b 
-I)d+R,[C] i=1,2
TO T
The relaxivity is also a function of the strength of the static magnetic field. The higher
the agent's relaxivity is, the less of it needs to be used to produce a contrast change in an
image.
The strength of the dipolar interaction between the water protons and paramagnetic
species is influenced by the proximity of the water protons. According to the location of
the water protons, the mechanisms of interaction and contribution to the relaxivity can be
classified as inner-sphere, second-sphere or outer-sphere effects. Inner-sphere mecha-
nism occurs when the water molecule binds in the primary coordination sphere of the
metal ion and exchanges with the bulk solvent. If the hydrogen-bounded water is in the
second coordination sphere and the lifetime of this interaction is long compared to the
time required for the solvent molecule and paramagnetic agent to diffuse past each other,
that is described as the second-sphere relaxation mechanism. Finally, outer-sphere re-
laxation refers to the relaxation mechanism of a water molecule diffusing past a para-
magnetic species. Due to the lack of deep understanding of the second-sphere coordina-
tion interactions, it is often not distinguished form the outer-sphere interactions (16). For
T, agents the inner-sphere mechanism is the most dominant contribution to the total re-
laxivity, while for T2 contrast agent the outer-sphere contribution tends to be the most
significant one.
The exchange of the water molecules between the bulk solvent and the primary
coordination sphere is the cause of the longitudinal contribution to the inner-sphere re-
laxation mechanism, as described by the following equation:
( )is = P1 PM M
T Tim +V-M
The variable Pm is the mole fraction of the metal ion, q is the number of the water mole-
cules bound to a metal ion, Tim is the longitudinal relaxation time of the bound water
protons and Tm is the lifetime of the water molecule in the complex. Tim is given by the
Solomon-Bloembergen equations (17, 18) which represent the sum of the two contribu-
tions, dipolar and scalar:
1 1 1
TDD TSCTM I I
1 B rCgp S(S+1) 3rc 7rc
DD 15 r1 + C21-2) (I+2 O)2
1 2 y(g2 + 4S( A)[e 2 -
sc 3 h (1+_ r2
1 _ 1 1 1
rC Te "M TR
1 1 1
Te Te 1M
The parameters here are: 71 is the proton gyromagnetic ratio, g is the electron g-factor, pB
is the Bohr magneton, S is the electron spin quantum number of the metal ion, r is the
distance from the center of the paramagnetic species to the center of the water proton
undergoing relaxation, ol and os are the Larmor frequencies for the nuclear and electron
spin and A is the electron-nuclear hyperfine coupling constant. The correlation times for
dipolar and scalar mechanism are rc and ue, T1e is the electron longitudinal spin relaxation
time and TR is the rotational correlation time of the whole metal-water complex. To opti-
mize the relaxivity, a couple of parameters from the above equations can be influenced
by an appropriate agent design. Typically, when designing T, contrast agents, the most
important parameters are the number of the coordinated water molecules to the central
metal ion, the distance between the water molecules and the metal ion, and the rotational
correlation time.
The outer sphere relaxation mechanism is a more complex problem centered on
solvation dynamics and diffusion. If the system consists of a dilute solution of small iso-
tropic paramagnetic species, than the contribution from each of them can be assumed to
be independent and additive. The most common type of paramagnetic species is iron ox-
ide particles. Many authors have addressed this problem (19), and the resulting expres-
sions have some similarity with the Solomon-Bloembergen equations. If the concentra-
tion of the paramagnetic particles is [C], their spin is S, gyromagnetic ratio ys and their
diffusion constant relative to the water protons is D (for which the protons can not ap-
proach closer than R, and for which the only contribution to the fluctuations in the local
magnetic fields comes from the diffusion of the protons past paramagnetic species); then
the paramagnetic contribution to the transverse relaxation is given by (20):
1 _16rc N [C]
-- - 051r yh 2 S(S+1) 100 [3j(coSTD I 3( 1  )+ 4(0)]
T2 405 ' 1000 RD
where TD, the diffusion correlation time, is the time needed to diffuse a distance on the
order of R:
D=R 
2
D
The spectral density functions j(o) are given by:
j(w) = Re
1+ -(icol-D) 2
4
1 4
1+(irD) I+(iwrD)±2 9
1
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and the secular term j (0) =1. Diffusion coefficients can be estimated if the motion can
be described by the diffusion of rigid spheres in a medium of viscosity q:
D kBTD = kB
6rcR rq
A condition for the validity of the theory is that
(o)'<1
3'
where 6o is the change of the equatorial magnetic field at the surfaces of the particles. In
NMR, this is typically referred to as the motional averaging regime. Under this condi-
tion, the same amount of paramagnetic material is much more effective in promoting
transverse relaxation of water protons when distributed as fewer larger particles than as a
greater number of smaller ones. With the increase of the paramagnetic particle size, the
T2 relaxation constant becomes smaller.
However, as the particle size increases, the basic assumptions for outer sphere re-
laxation theory are no longer valid, since, among other factors, the local magnetic field
contributions from paramagnetic particles start to overlap. Once (So)TD is greater then 1,
which is referred to as the static dephasing regime, the relationship between the paramag-
netic particle size and T2 relaxation rate becomes inverse: with increase of particle size
the relaxation rates are slower. This has been extensively explained by the theoretical
work of Gillis and colleagues (21-23). Another notable characteristic of the static
dephasing regime is that T2* remains roughly constant with the increase of the particle
size, whereas it decreases in the motional averaging regime.
1.5. Contrast agent classification
MR contrast agents can be divided into three groups: nonspecific, targeted and re-
sponsive (Figure 2) (24). Nonspecific contrast agents are exemplified by blood pool
agents such as Gd-DTPA that show a relatively nonspecific distribution pattern. They are
not used to access molecular targets. Targeted contrast agents are conjugated to affinity
ligands, such as peptides, antibodies or small molecules that impart molecular specificity
to the probe and work in analogous way to PET probes. They are especially useful in
detection of cell surface proteins, such as receptors expressed by cancer cells. Respon-
sive contrast agents change their relaxivity upon interaction with a specific target. They
are often assumed to exist in two states, "off' and "on", one which is of lower and the
other one higher relaxivity. The switch from one to the other state occurs when the con-
trast agent binds its target. This type of contrast agent is also referred to as bioactivated.
Typical parameters to which smart contrast agents can be responsive to are pH, oxygen
pressure, temperature, enzymatic activity, redox potential, as well concentration of spe-
cific molecules such as DNA, proteins, small molecules, ions, etc.
Responsive T1 contrast agents are typically small chelates of paramagnetic metals,
for which some relaxivity determinant changes upon the interaction with specific molecu-
lar target. One of the parameters that can be controlled in such a way is solvent accessi-
bility. A typical design of such a responsive contrast agent involves a group that blocks
water protons from exchanging with the paramagnetic metal ion, and once the target
binds the contrast agent, intramolecular rearrangement occurs, that removes the blocking
group away from the central metal ion allowing access to water molecules. This increases
q, the total number of water molecules bound to the metal ion, which promotes the Ti
relaxation rate. An example of such a contrast agent is "EgadMe" designed by Meade
and colleagues (Figure 3A) (25). In this agent, Gd-ion is caged by an enzymatically
cleavable substrate (galactopyranoside). In the presence of the target enzyme, p-
galactosidase, the substrate is cleaved, exposing the Gd-ion to the water and increasing q.
This increases Ti relaxivity about three times. This agent can be used for monitoring
gene expression if p-galactosidase is used as a marker for gene expression from specific
promoters, as was demonstrated in injected embryos of Xenopus laevis. Another parame-
ter than can be controlled in responsive Ti contrast agents is the spin state of the para-
magnetic atom. Hemoglobin, the iron-containing protein responsible for oxygen transfer
in the blood works this way. In the deoxy state, the protein is paramagnetic since Fe2
ions have unpaired electrons. Once oxygen is bound, these electrons become paired
which makes the oxy-hemoglobin diamagnetic. This makes hemoglobin an effective
oxygen sensor, allowing it to sense regional oxygen tension (pO2) (26). This same effect
is also the basis for BOLD effect, the main method used in modem fMRI. Yet another T1
relaxivity determinant, rotational correlation time, increases if the target is a molecule
that is much larger than the paramagnetic chelate. Binding of a protein molecule to a
small paramagnetic chelate can result in relaxivity changes of more than one order of
magnitude.
T2 contrast agents are typically superparamagnetic iron-oxide particles. Based on
their size, they can be classified as ultra-small nanoparticles (r 50 nm) (USPIOs), small
nanoparticles (50 nm r 1 im) (SPIOs) or micron-sized (r > 1p im). These agents can
be detected at much lower concentrations (submicromolar) than T, contrast agents due to
their high T2 relaxivity, which is greatly influenced by their size and microscopic spatial
distribution in the solution (27). Clustering of these particles is the basis for sensing a
particular molecular target. Weissleder and colleagues (28, 29) designed the first re-
sponsive contrast agents based on nanoparticle aggregation by conjugating the nanoparti-
cles to a pair complimentary oligonucleotide sequences. A crosslinked network was
formed, that disaggregated upon the addition of a restriction nuclease (Figure 3B). This
resulted in 5-fold change in T2 relaxivity. A similar mechanism was used to produce ag-
gregation-based contrast agents for sensing of other enzymes, protein-protein interac-
tions, DNA, viruses etc. (30). These types of sensors are sometimes referred to as mag-
netic relaxation switch. The interaction with the specific target causes the particle aggre-
gation and concomitant large changes in T2 due to the changes in local magnetic field
gradient that water protons diffusing past these agents are experiencing. Some of these
sensors can be designed to be reversible, so that, once the target is removed from the sys-
tem or its concentration drops below a certain critical value the particle clusters disaggre-
gate back to the original, dispersed state.
Appendix A discusses key quantitative considerations connected to design, mecha-
nism and application of smart MRI contrast agents (31).
1.6. MRI contrast agents for molecular imaging of brain activity
MRI continues to have a tremendous impact in neuroscience and in brain disease
diagnostics and treatment. A whole array of methods has been developed for anatomical,
functional and molecular imaging of the brain (32). The field continues to show rapid
progress. Functional MRI methods have blossomed with the development of the BOLD
technique. However, due to some inherent limitations of this method, it can not be ap-
plied to study neural activity at the cellular level. For that, MRI should be performed in
conjunction with contrast agents that can detect certain aspects of neural physiology.
There has been a significant improvement in the development of such probes in the recent
years, although most have still not been shown in work in live, functioning animal brains.
There are some limitations when it comes to use of these agents in vivo, such as toxicity
and delivery. Many MRI contrast agents incorporate metals such as gadolinium and man-
ganese which are extremely toxic even at very low concentrations, so they are usually
complexed with organic molecules that make the concentration of the free metal much
lower. Another significant challenge is delivering the agents through blood-brain barrier.
MRI contrast agents have been developed that target metabolic activity, pH, gene expres-
sion in the brain, as well as metal ions (calcium, zinc, copper) important in signaling of
the neural networks. This section reviews the first three groups, while probes that target
calcium are discussed in more details in the subsequent section.
Uptake and processing of some cerebral metabolites is closely correlated with neu-
ronal activity. Hemoglobin has been used as an oxygen-responsive contrast agent, both as
an endogenous protein (which underlies the BOLD effect) and as an exogenous contrast
agent to detect local partial oxygen pressure in the tissue (26). Traditionally, PET has
been widely used in conjunction with FDG to study cerebral metabolites. A somewhat
similar approach with MRI has been demonstrated by Golman et al. (15) who used hyper-
polarized 13 C labeled pyruvate to study the kinetics of the pyruvate uptake as well as its
turnover to lactate. Since 13C MRI is usually not sensitive enough at the typical concen-
trations of pyruvate in the tissues, dynamic nuclear polarization method has been used to
significantly boost the 13 C signal. The main drawback of this method is the short time
window available for imaging due to the T, relaxation of the hyperpolarized 13C, so the
agent needs to be continuously administered during imaging studies longer than a minute.
Both relaxation and CEST-based MRI contrast agents can be designed to be pH-
sensitive and therefore used to monitor neural activity since a slight acidification of the
extracellular medium is characteristic of this activity (33). These changes are typically in
the range from pH 7.2 to 7.4. A contrast agent based on phosphonated Gd3 has been
used by Garcia-Martin et al. (34) to look at intravascular acidification in rat glioma. It
could distinguish differences in pH on the order of one pH unit, and it could in principle
be used for functional brain imaging, although it might not be sensitive enough under
realistic conditions. A different approach for pH-imaging of the brain is to use the CEST
mechanism of endogenous amide protons, which has been demonstrated in detection of
focal ischemia in rats (35).
Biology has benefited tremendously from the discovery of green fluorescent protein
(GFP) (36) and the subsequent development of smart fluorescent GFP-based probes such
as chameleons (37). There have been significant efforts in the past decade towards engi-
neering of equivalent reporter genes that modulate MRI contrast. There are couple of
approaches that have been employed in this endeavor: (1) enzyme-based reporter genes,
where enzymes cleave functional groups that block proton exchange or binding MRI con-
trast agents; (2) expression of surface receptors that enable binding of specific MRI con-
trast agents, (3) design of artificial CEST-based reporter gene and (4) expression of iron-
containing metalloproteins such as ferritin and transferrin receptor, that promote T2 re-
laxation (38-40). Previously described "EgadMe" contrast agent is an example of the
first group. This sensor can detect the activity of the enzyme p-gal which is encoded by
the LacZ gene. Transferrin conjugated to SPIOs, used to target the transferrin receptor in
vivo (41), is a typical representative of the second approach. An artificial, lysine-rich
protein (LRP), which contains a high density of amide protons, was cloned and expressed
in rat glioma cells and detected in the mouse brain in xenografts of LRP-expressing cells
(42). This CEST-based reporter gene has typical characteristic of CEST agent contrast
agents: it is switchable, but suffers from low sensitivity. Finally, there has been consider-
able interest in iron-based reporter genes such as ferritin. Genove et al. has demonstrated
its use as an MRI reporter gene by injecting adenovirus encoding for human ferritin in
mouse brain, which resulted in significant loss of signal in the T2-weighted image (43).
Coexpression of ferritin and transferring receptor in neuronal stem cells produced a simi-
lar effect (44). Recently, Shapiro et al. demonstrated a smart, aggregation-based T2 con-
trast agent based on ferritin as well (45). In that work, a system was developed to express
self-assembled ferritin nanoparticles, incorporating multiple surface functionalities,
which were subsequently used to produce a protein kinase A sensor. Mag A, a bacterial
iron transporter from a type of magnetotactic bacteria, has been expressed in 293FT cells
under the regulation of doxycycline (46). A significant signal loss in T2*-weighted im-
ages was shown upon the inoculation of these cells in a mouse brain.
1.7. Calcium-sensitive contrast agents for fMRI
Calcium ions have an important role as secondary messengers in cellular signaling
pathways and many groups have focused on developing MRI contrast agents that would
be responsive to calcium. The dominant isotope of calcium, 40Ca, accounts for 96.94 %
of the natural abundance and can not be directly imaged with MRI because it has zero
nuclear spin.
There are a number of factors that make neuronal calcium ion concentration fluc-
tuations an optimal target for fMRI imaging agents. First, calcium levels are closely cor-
related with the firing rates of neurons, which would make calcium readout of neural ac-
tivity much more direct that the readout based on BOLD effect. Second, calcium levels in
the neurons usually fluctuate on a timescale that might be appropriate for detection by the
fastest MRI methods (100-1000 ms). The concentrations of other important ions, as well
as the voltage, fluctuate much more rapidly (on the order of 1-10 ms) and are not possible
to detect with MRI in its current state of development. Third, the changes in neuronal
calcium concentrations are quite dramatic, ranging from 0.1-1.0 pM in the cytoplasm and
0.1-100 gM near boutons during synaptic depolarization. Extracellular calcium concen-
trations also fluctuate during neuronal activity, although the changes are less specific.
The typical range of these changes is from 1.2 mM to 0.8 mM, although in some patho-
logical cases the changes can be much more pronounced. These fluctuations could also be
targeted by appropriately designed fMRI calcium sensors. Finally, there are a number of
fluorescent calcium imaging agents that have successfully been used for optical imaging
of neurons, which could be used as basis for the design of the MRI sensors (37).
Bis(aminophenoxy)ethane tetraacetic acid (BAPTA) is well known calcium chela-
tor that is often used in the design of the calcium sensors. In 1983, a fluorinated deriva-
tive of BAPTA was produced by Smith et al. for 19F magnetic resonance measurements
(47). Years later, 19F-BAPTA was used for quantitative calcium measurements (48).
However imaging with this molecule is not very practical because of its low concentra-
tion. Even at very high concentrations of this molecule, such as 1mM, the method is still
5 orders of magnitude less sensitive that standard proton imaging. The first relaxation
promoting MRI sensor for calcium developed by Li et al. also involves BAPTA molecule
in its design (Figure 4A) (49). This paramagnetic T, contrast agent, Gd-DOPTA, consists
of a derivative of the BAPTA molecule attached to two copies of Gd3*-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraaacetic acid (Gd-DOTA). This molecule has a Ca2+
dissociation constant of~ 1 pM and its relaxivity increases approximately 80 % (from 3.3
to 5.8 mM-I s.1 at 11.7 T) upon addition of the calcium ion to a calcium-free solution. In
the absence of the calcium, the Gd3 * coordination sphere is completed by two closest
carboxylic groups of BAPTA. Once calcium is added, these groups now bind this ion,
allowing two water molecules to complete the Gd3 * coordination sphere, which promotes
Ti relaxivity due to the increase in q. The response to calcium is fairly fast because it
involves intermolecular rearrangement. This agent has yet to be used for functional imag-
ing of neural activity in vivo. A different type of Ti contrast agent based on chelated
Gd 3 that targets extracellular calcium has been introduced by Logothetis and colleagues
(50). Zinc ions are also influenced by neuronal activity and a couple of contrast agents
for targeting of the zinc ions have been developed. Recently, a contrast agent similar to
that of Li et al. has been introduced for zinc sensing (Figure 4B) (51). This contrast agent
is based on manganese-containing porphyrin molecule. It has Ti relaxivity comparable
to that of Gd3 * agents, but a significant advantage of being cell permeable. Zinc-
dependent signal changes have been demonstrated in cells incubated with this contrast
agent.
A different approach to imaging neural activity has been introduced by Koretsky
and co-workers, using paramagnetic manganese ions as Ca2+ analog. Mn2+ ions produce
signal enhancement in Ti-weighted images that is coupled to neuronal activity (52).
Mn2+ can enter excitable cells using some of the same transport systems as Ca 2+ such as
voltage-gated calcium channels. Manganese ion can bind a number of intracellular sites
because it has high affinity for Ca2+ and Mg2+ binding sites in nucleic acids and proteins
(53). Activity dependent accumulation of Mn2+ has been demonstrated when it was ap-
plied near receptory neurons in olfactory epithelium of a mouse (54). Once it was deliv-
ered past the blood-brain barrier, it was observed that accumulation of Mn2+ in rat neu-
rons is slow, on the order of minutes, and its excretion from cells is even slower, some-
times on the order of days (55, 56). This means that Mn2+ can serve as a marker for neu-
ral activity history, but that Mn2+ fluctuations in the brain are too slow for real time func-
tional imaging. Mn2+ can therefore be used to label active neurons during sensory or be-
havioral tasks performed outside the magnet. This technique is somewhat analogues to
the use of 2-deoxyglucose for activity mapping by autoradiography. It was recently used
for Ti-weighted mapping of auditory cortex in mice (57) and for functional brain studies
in developing insects (58). A major drawback to the use of Mn2+ is its cellular toxicity,
so the dose used should be as low as possible.
1.8. Basis and potential advantages of calcium sensors based on aggregation of
superparamagnetic iron oxide nanoparticles
The goal of this thesis work is to develop MRI contrast agents that can be used to
image neuronal calcium in vivo at high temporal and spatial resolution. We believe that
the best approach to do so is to design a calcium sensitive contrast agent based on the
aggregation of SPIOs which have high T2 relaxivities. In order to make the SPIO aggre-
gation sensitive to calcium, proteins that bind each other in a calcium-dependent manner
are conjugated to nanoparticles. Many proteins associate and dissociate reversibly de-
pending on the local calcium concentrations. Calmodulin (CaM) is a very well studied
protein that binds a number of targets in a calcium-dependent fashion. The CaM struc-
ture is characterized by a helix-loop-helix organization. The protein has four EF-hand
structures than can bind calcium in a cooperative manner. Upon calcium binding, an
intramolecular conformational change in the structure of the protein occurs, which allows
CaM to bind its target (Figure 5). Most CaM binding partners are short basic peptide
sequences. The peptide sequences chosen for this work are M13, which is derived rabbit
skeletal muscle myosin light chain kinase, and RS20, derived from smooth muscle my-
osin light chain kinase. Reversible binding of CaM and M13 dependent on calcium con-
centration has been detected in cells using fluorescent methods (59). A fluorescent cal-
cium sensor based on the CaM - M13 binding has previously been developed (Figure 6)
(37). Our MRI calcium sensor consists of a binary mixture of SPIOs conjugated to the
protein and to the peptide, which should form clusters if the calcium concentration is
above a particular threshold.
There are numerous advantages of this type of sensor over previously described
paramagnetic small molecules. SPIOs have relaxavities which are typically an order of
magnitude greater than those of complexes of paramagnetic metals. Upon aggregation
changes of relaxivities may be significantly greater than those achievable with T, contrast
agents. This type of sensor may be used at significantly lower concentrations than the
small molecule sensors. Therefore, it is unlikely that these sensors would buffer intercel-
lular calcium. The timescale on which SPIOs influence T2 contrast is quite fast, so these
agents might be able to achieve a significantly better temporal resolution. Since SPIOs
have been already used in different scientific fields, such as cell trafficking, there are
already some published methods on cell delivery of these agents (60). Finally, because
this sensor is part protein, tools of molecular biology may be used to control the interac-
tion driving the aggregation.
Despite these advantages, there are also a number of issues when it comes to appli-
cation of this type of sensors in cells and organisms. Large SPIOs may diffuse infectively
through the cytoplasm, especially if they are larger than 50 nm. Since the T2 relaxation
of the water molecules depends on their diffusion in the vicinity of SPIOs, compartmen-
talization of the water molecules and nanoparticles within the cells will generally make
T2 values different from those measured in vitro. Toxicity and delivery to cells in the
brain might also present challenges for in vivo use of SPIO-based sensors.
This thesis has two main goals. The first is to develop and demonstrate in vi-
tro a prototype calcium sensor based on SPIO aggregation that would be potent, reversi-
ble, tunable and suitable for detection of typical intracellular fluctuations of calcium con-
centrations. The second aim is to design the next generation of the sensor based on much
smaller nanoparticles that would address the issue of the diffusivity of the larger SPIOs.
The two following chapters describe the work on both of these goals, respectively.
1.9. Organization of thesis
This thesis is organized in four chapters. The second chapter, titled "Calcium-
sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and
calmodulin", describes the work on our prototype sensor designed in above described
manner using commercially available SPIOs. Chapter 3, titled "MRI calcium censors
based on crosslinked lipid-coated iron oxide nanoparticles" describes our work on the
second generation of the sensor based on much smaller crosslinked lipid-coated iron ox-
ide nanoparticles (LCIOs). The final, fourth chapter provides conclusions and future
directions, and discussion of the limitations that need to be overcome for the in vivo use
of this sensor. It is followed by an appendix titled "Dynamic imaging with MRI contrast
agents: quantitative considerations" which discusses theoretical considerations important
in design of the MRI sensors.
FIGURE LEGENDS
Figure 1. Contrast mechanisms in molecular MRI. Signal in MRI is proportional to
the concentration of directly detected nuclei (usually protons in water molecules), their
polarization, manipulations through pulse sequences and relaxation rates. (A) An exam-
ple of Ti contrast agent, gadolinium-diehtylenetriaminepentaacetic acid (Gd-DTPA).
Water molecules interact with paramagnetic Gd3 through space or through direct coordi-
nation, which promotes Ti relaxivity. If MRI is performed using Ti-weighted pulse se-
quences, this results in image brightening. (B) Superparamagnetic iron oxide nanoparti-
cle (SPIO), a typical T2 contrast agent. SPIOs induce perturbations in the local magnetic
fields that induce relaxation of water molecules diffusing in proximity. This results in
reduction of MRI signal and image darkening. (C) An example of chemical exchange
saturation transfer (CEST) contrast agent is 5-hydroxytriptofan which contains an indole
nitrogen proton that exchanges with the bulk water. Application of the saturation pulse at
the frequency of indole proton indirectly reduces the signal from water molecules, which
leads to darkening of the MRI image. (D) Contrast agents incorporating nuclei such as
13 C and 19F may be imaged directly by MRI. An image obtained by Goldman et al. us-
ing spectroscopic imaging techniques to image hyperpolarized 13Cpyruvate and its meta-
bolic product, 13C-lactate.
Figure 2. Classification of MRI contrast agents. (A) Nonspecific contrast agents such
as blood pool agents, show a relatively nonspecific distribution pattern. (B) Targeted con-
trast agents, which bind by specific ligands to protein structures on cell surface. (C) Re-
sponsive contrast agents which are activated by an interaction with specific target.
Figure 3. Examples of responsive T1 and T2 contrast agents. (A) A reporter for p-
galactosidase activity called EgadMe from Louie et al. Upon the cleavage of the sugar
group by the enzyme at the red bond site, an inner sphere coordination site of the Gd 3
becomes more accessible to water molecules. (B) A T2 contrast agent based on SPIO ag-
gregation from Perez et al. SPIOs cluster in the presence of a target which changes T2
relaxation time. The clusters of SPIOs can be dispersed by the action of the enzyme or
other factors.
Figure 4. Examples of previously developed T1 contrast agents for metal ion sensing.
(A) A Ca 2-sensitive contrast agent from Li et al., based on Ca2+ chelator BAPTA and
Gd-DOTA. In the absence of Ca2+, carboxylic groups of BAPTA are coordinating para-
magnetic Gd3 * ion. Once Ca2+ binds, these ligands rearrange to bind this ion, increasing
inner sphere water accessibility to the complex which results in the increase of Ti relaxiv-
ity. (B) A cell permeable, manganese-containing porphyrin molecule that senses Zn2+ ion
from Zhang et al. Binding of the zinc causes intramolecular rearrangement which ex-
poses central Mn 3+ to water promoting the Ti relaxation rate of the complex.
Figure 5. Structure and calcium-dependent substrate binding of calmodulin.
Calmodulin is a protein whose structure is characterized by four calcium binding motifs.
These motifs have a helix-loop-helix structure (EF hands). CaM has two globular do-
mains linked by a flexible linker. Each domain consists of a pair of EF hands connected
by a linker region and binds two Ca2+ with positive cooperavity. The binding of Ca2+
causes an intramolecular conformation change that allows the protein to bind its target.
Figure 6. Design of a fluorescent calcium sensor based on CaM-M13 interaction.
Sensors called cameleons, from Miyawaki et al., consist of tandem fusions of blue- or
cyan- emitting mutant of green fluorescent protein (GFP), calmodulin, the calmodulin-
binding peptide M13 and an enhanced green- or yellow- emitting GFP. Binding of Ca 2+
causes calmodulin to wrap around M13 which increases the fluorescent resonance energy
transfer (FRET) between the flanking variants of GFP.
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2. Calcium Sensors for Magnetic Resonance Imaging Based on Super-
paramagnetic Iron Oxide Nanoparticles and Calmodulin
The work described in here is the basis of the research paper that has been pub-
lished in a peer reviewed journal (81). We introduce a new family of calcium indicators
for magnetic resonance imaging (MRI), formed by combining a powerful iron oxide
nanoparticle-based contrast mechanism with the versatile calcium sensing protein
calmodulin and its targets. Calcium-dependent protein-protein interactions drive particle
clustering and produce up to fivefold changes in T2 relaxivity, an indication of the sen-
sors' potency. A variant based on conjugates of wild-type calmodulin and the peptide
M13 reports concentration changes near 1 ptM Ca2+, suitable for detection of elevated
intracellular calcium levels; the midpoint and cooperativity of the response can be tuned
by mutating the protein domains that actuate the sensor. Robust MRI signal changes are
achieved even at nanomolar particle concentrations (less than 1 pM in calmodulin), that
are unlikely to buffer calcium levels. When combined with technologies for cellular de-
livery of nanoparticulate agents, the new sensors and their derivatives may be useful for
functional molecular imaging of biological signaling networks in live, opaque specimens.
INTRODUCTION
Calcium ions (Ca 2+) have been a favorite target in molecular imaging studies be-
cause of the important role of calcium as a second messenger in cellular signaling path-
ways. Fluorescent calcium sensors are used widely in optical imaging, both at the cellu-
lar level and at the cell population level. Calcium-sensitive dyes have recently been used
in conjunction with laser scanning microscopy to follow neural network activity in small
three-dimensional brain areas (61), and to characterize patterns of interaction among cells
in developing vertebrate embryos (62). Due to the scattering properties of dense tissue,
high resolution optical approaches like these are usually limited to superficial regions of
specimens, and to restricted fields of view (63). To probe calcium dynamics more glob-
ally in living systems, a different imaging modality must be used.
Magnetic resonance imaging (MRI) is an increasingly accessible technique for im-
aging opaque subjects at fairly high spatial resolution, and MRI studies of calcium dy-
namics could in principle complement optical approaches by offering both greatly ex-
panded coverage and depth penetration in vivo (64). Calcium isotopes are unsuitable for
direct imaging by magnetic resonance, so attempts to sensitize MRI to calcium have fo-
cused around the use of molecular imaging agents. Fluorinated derivatives of the biva-
lent cation chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA)
have allowed calcium measurements in vivo by 19F MRI, but only at approximately 10-
the sensitivity of standard MRI methods (47, 48). Two potentially more powerful proton
Ti relaxation-promoting contrast agents have been introduced subsequently. The para-
magnetic ion manganese (Mn2+) mimics calcium by entering cells through calcium chan-
nels; because it accumulates much faster than it is removed, Mn2+ produces an "integral"
of calcium signaling history that can be detected as brightening in Ti-weighted images
(52). A gadolinium complex synthesized by Meade and colleagues acts as a T, calcium
sensor analogous to BAPTA-based probes (49), and may be more compatible with time-
resolved calcium imaging than either Mn2+ or 19F-BAPTA.
A general limitation of MRI molecular imaging strategies is the relative insensitiv-
ity of the method to most molecular probes (16). With conventional paramagnetic con-
trast agents and typical measuring conditions, 10-100 ptM concentrations are required for
robust visualization (cf less than 1 ptM for most fluorophores or picomolar quantities for
nuclear imaging tracers). For this reason, considerable interest has focused on the use of
superparamagnetic iron oxide nanoparticles (SPIOs) (10). SPIO contrast agents are large
macromolecules of 50 nm diameter or less, containing small crystals of permanently
magnetized material; they can be detected by T2-weighted imaging at sub-micromolar
particle concentrations and at total iron concentrations an order of magnitude below con-
ventional sensitivity limits. The first SPIO-based MRI sensors were produced by
Weissleder and colleagues, who synthesized a series of probes for oligonucleotide and
protein interactions (28, 29). These agents produce dramatic T2 contrast changes, due to
reversible aggregation of appropriately functionalized SPIOs. In this paper we introduce
a potent, tunable MRI calcium sensor family that combines the advantages of SPIO
agents with protein-based mechanisms used previously in the construction of fluorescent
calcium probes (37).
MATERIALS & METHODS
Protein and peptide synthesis. Biotin-M13 and biotin-RS20 were synthesized by
standard Fmoc chemistry; lysine-(Ns)-biotin was added as the N-terminal residue, spaced
by a glycylglycine linker, such that the full sequences were biotin-KGGKRRWKKNF-
IAVSAANRFKKISSSGAL (M113) and biotin-KGGRRKWQKTGHAVRAIGRLSSS
(RS20). Peptides were purified by standard C18 reversed-phase high pressure liquid
chromatography, assayed by mass spectrometry, and stored in phosphate-buffered saline
(PBS), pH 7.2, at 4 'C. Bovine CaM was purchased from Sigma (St. Louis, MO) and
biotinylated by reaction with one molar equivalent of NHS-LC-biotin (Pierce Biotech-
nology, Rockford, IL), according to the manufacturer's protocol. The number of biotins
per protein molecule was quantified using the HABA-avidin assay (Pierce), using an
OD 2 80 for CaM of 3,000 M-1 cm'1. This quantity was generally 0.2-0.7, meaning that
most CaM molecules had either zero or one biotin attached; this served to limit the poten-
tial for nonproductive conjugation and biotin-mediated crosslinking of SPIO nanoparti-
cles. Expression vectors for recombinant CaM variants were derived from a Xenopus
CaM gene (XCaM E104Q; referred to in the text as Xl) generously provided by Atsushi
Miyawaki. Standard molecular biology techniques were used to modify the gene with
coding sequences for a hexahistidine tag and a free cysteine near the N-terminus; se-
quencing of the clones also indicated presence of the nonstandard substitution D64Y.
The S81R/E83K/E87R/E104Q mutant (referred to as X2) was generated from this tem-
plate using PCR-based techniques. Recombinant XCaMs were expressed in E. coli and
purified using nickel-affinity chromatography. Each protein was biotinylated at its free
cysteine by reaction with excess biotin-BMCC (Pierce), and then repurified by gel filtra-
tion (Sephadex G-25). Expressed proteins were assayed by SDS polyacrylamide gel
electrophoresis and mass spectrometry, and were stored in PBS, pH 7.2, at 4 'C for up to
two weeks.
Formation of conjugates. Strepatividin-coated SPIO particles (SA-MACS) were
purchased from Miltenyi Biotec (Auburn, CA). To form conjugates, biotinylated poly-
peptides were mixed in approximately five-fold excess with SA-MACS nanoparticles and
incubated for 30 minutes at room temperature. The reaction mixture was passed over a
magnetic separation column and washed with phosphate-buffered saline before elution of
the formed conjugates. Saturation of biotin-binding sites was confirmed using a fluores-
cent biotin titration assay, with biotin-4-fluorescein purchased from Molecular Probes
(Eugene, OR). Iron content of SA-MACS stock solutions was determined using flame
atomic absorption spectroscopy, which indicated an OD 450 for SA-MACS of 12 (g/L Fe)~
cm1 or 690 (M Fe)~1cm-1. Concentration of biotin sites in SPIO stock solutions was
quantified using biotin-4-fluorescein titration; the number of biotin sites per particle
(-60) was estimated assuming 75,000 Fe atoms per particle.
Light scattering experiments. Dynamic light scattering (DLS) measurements
were performed using a DynaPro DLS system (Wyatt Technology, Santa Barbara, CA).
For each sample or condition, a single intensity weighted value was used to characterize
the average size of all particles in the specimen. The absolute radius observed for uncon-
jugated SA-MACS was roughly 50 nm, which is consistent with an actual distribution of
radii from 10-50 nm reported by the manufacturer, given the tendency of DLS to over-
emphasize large molecular weight species. Throughout this paper, mean hydrodynamic
radii for individual samples are reported relative either to SA-MACS-CaM or to calcium-
free binary mixtures of CaM- and target-conjugate SPIOs; absolute measurements, except
for histograms (Figure 2B), are skewed toward large radii and do not reflect the actual
particle size distributions present. Most DLS measurements were obtained after 60 min-
utes of incubation in the reported buffer condition, with 200-fold averaging and a one
second integration time; error bars denote standard errors of the mean. Time course ex-
periments were initiated by manual 1:1 dilution of premixed CaM- and M13-conjugated
SPIOs incubated for one hour in either 100 p.M CaCl2 or 100p.M EDTA into final con-
centrations of 500 p.M CaCl 2, 500 p.M EDTA, or control (initial) conditions. Mixing
dead time for DLS kinetic experiments was approximately 5 seconds, and each measure-
ment was averaged over a 20-second time window. Calcium titration data were obtained
from SPIO suspensions with 7.9 mg/L Fe using 0-39 p.M Ca/EGTA buffers (Molecular
Probes) and unbuffered 3-3000 p.M CaCl2 solutions. Calcium titration was performed in
100 mM KCl, 30 mM MOPS, pH 7.2; all other measurements were performed in phos-
phate-buffered saline, pH 7.2. Graphing and curve fitting were performed with Kaleida-
graph (Synergy Software, Reading, PA). EC50 's for calcium binding were obtained by
fitting DLS data to the equation: r = cI[Ca2+]"/(ECso" + [Ca2+]") + C2, where r is the rela-
tive radius, ci and c2 are constants, and n is a cooperativity parameter.
Atomic force microscopy. Atomic force microscopy (AFM) was performed using
a Veeco Instruments (Woodbury, NY) D3000 atomic force microscope in tapping mode
with a silicon cantilever (30 x 125 pm, 265 kHz resonance). SA-MACS conjugates pre-
pared as described above were mixed and incubated in 100 p.M CaCl2 or 100 p.M EDTA
buffers at room temperature for one hour. Nanoparticle mixtures were then pipetted onto
freshly cleaved mica disks (Electron Microscopy Sciences, Hatfield, PA) and incubated
for a further two hours to allow adhesion to the substrate. The mica samples were then
washed with deionized water and dried with air before imaging. In order to optimize
sample loading onto the mica substrates, SPIO concentrations used for these experiments
were 2.5-10 times higher than for DLS experiments.
Magnetic resonance imaging. Imaging was performed on a 40 cm bore Bruker
(Billerica, MA) Avance 4.7 T scanner equipped with 26 G/cm triple-axis gradients, and
using a birdcage coil (Bruker) for radiofrequency transmission and detection. Samples
for imaging were pipetted into microtiter plate wells, sealed with plastic adhesive covers,
and loaded onto a plastic tray in the imaging probe. To minimize susceptibility-related
distortions in the MRI, unused wells of each plate were filled with PBS, and imaging was
performed on a 2 mm slice selected at the middle of each microtiter plate well (parallel to
the plate). A T2-weighted spin echo pulse sequence was used, with Carr-Purcell-
Meiboom-Gill (CPMG) acquisition of eight two-dimensional echo images per excitation.
For images presented in this paper, TR was 2 s and TE ranged from 10 ms to 80 ms, in 10
ms increments (i.e. 2r for CPMG acquisition was 10 ms). Data were acquired as matrices
of 512 x 128 points for each echo image and zero-filled to 256 points in the second
(phase encoding) dimension. To produce kinetic data for Figure 4, a series of such im-
ages was acquired over one hour, with a mixing and setup dead time of about four min-
utes and an acquisition time of eight minutes per image. Images were reconstructed and
analyzed using custom routines running in Matlab (Mathworks, Natick, MA). For calcu-
lation of ratio images (Figure 3B, 5B, and 5D) segmentation was performed to zero back-
ground noise contributions. Relaxation rates and relaxivities reported in the text were
calculated by exponential fitting to the image data. All data analysis was performed us-
ing Matlab and Kaleidagraph.
RESULTS & DISCUSSION
Calcium sensor principle. The microscopic spatial distribution of SPIO particles
has a great effect on their ability to influence local T2 relaxation rates in aqueous media
(27, 28). This principle was used recently to construct a number of SPIO-based sensors
for protein and nucleic acid interactions (30). In each case, the formation or disruption of
an interaction of interest resulted in a change in the aggregation state of SPIO particles
conjugated to the interacting moieties; remarkably large concomitant changes in T2 con-
trast were observed by MRI. We were interested in whether a similar effect could be
coupled to changes in calcium concentration to produce a calcium sensor. A number of
proteins are known to associate and dissociate reversibly as a function of calcium concen-
tration (66). Some of the best-studied calcium-dependent interactions take place between
the calcium-binding protein calmodulin (CaM) and a series of short basic target peptides
(67), most prominantly a sequence (M13) derived from rabbit skeletal muscle myosin
light chain kinase (68). Reversible calcium-dependent binding of CaM and M13 domains
can be detected in cells using fluorescent methods (37, 59). We therefore predicted that
if CaM and M13 were conjugated separately to two distinct SPIO populations, a binary
mixture of the two species could aggregate selectively in the presence of calcium and
could thus constitute an MRI calcium reporter (Figure 1).
We used commercially-available SPIO nanoparticles coated with the Streptomyces
avidinii protein streptavidin (SA-MACS, Miltenyi Biotec). These particles have an over-
all diameter of 20-100 nm, and contain roughly 50% Fe 2O 3 with core diameters of ap-
proximately 10 nm (69). They have a T2 relaxivity (the slope of T2 relaxation rate vs.
concentration) of 410 ± 10 s-1 mM-1 Fe at 4.7 T, and little measurable T, relaxivity, and
they contain roughly 60 biotin-binding sites per nanoparticle (see experimental section).
To construct calcium sensors based on the SA-MACS nanoparticles, biotin-M13 and bio-
tin-CaM were produced and conjugated to the functionalized SPIOs. To test the general-
ity of the proposed CaM-based sensor mechanism, we also produced conjugates using a
second CaM target peptide, RS20, which is related to M13 but derived from smooth mus-
cle myosin light chain kinase. Biotin-M13 and biotin-RS20 were both produced by solid
phase synthesis. Biotin-CaM was produced from purified bovine CaM by reaction with
biotin-LC-NHS (< 1 biotin/CaM). Biotinylated species were then coupled to SA-MACS
via the high-affinity streptavidin/biotin interaction, and excess uncoupled protein was
removed using a magnetic column to yield the final reagents, SA-MACS-M13, SA-
MACS-RS20 and SA-MACS-CaM. These products were stable in 0.1% BSA for up to
one week at 4 'C.
Calcium-dependent aggregation of SPIO conjugates. We first characterized
calcium-dependent aggregation behavior of the SPIO conjugates by dynamic light scat-
tering (DLS). Figure 2A shows relative average hydrodynamic radii measured for SA-
MACS-CaM, SA-MACS-M13, SA-MACS-RS20, and binary mixtures, recorded in 500
pM CaCl2 (grey bars) or 500 pM EDTA (white bars), with SPIO concentrations totaling
7.9 mg/L Fe. In no case did the measured mean radius of the unmixed conjugate species
display calcium dependence. M13- and RS20-conjugated particles displayed somewhat
larger radii than SA-MACS-CaM, presumably due to a weak tendency of these particles
to self-associate in solution. Because of the predicted dependence of binary aggregation
phenomena on particle stoichiometry, we made four versions of sensor, varying both the
ratio of CaM-conjugate SPIOs to target conjugates, and the identity of the CaM target
sequence: 3C:lM and 1C:lM refer to mixtures of SA-MACS-CaM with SA-MACS-
M13 in 3:1 and 1:1 ratio, respectively; 3C:lR and 1C:lR refer to the corresponding sen-
sors incorporating RS20 instead of the M13 peptide. Under calcium-free conditions, the
1:1 sensors gave rise to mean radii slightly larger than the SA-MACS-M13 or SA-
MACS-RS20 particles alone, while the 3:1 sensors in EDTA had radii close to the aver-
age unmixed particle radius.
All of the sensor variants showed significant increase in relative radius in the pres-
ence of 500 pM CaCl2, compared with the calcium-free condition; 1C:lM and 1C:lR
gave increases approximately by a factor of two, while with 3C:lM and 3C: 1 R, the in-
crease was by a factor of roughly 1.5. The measurements reported in Figure 2A were
obtained after 60 minute incubation times; after longer incubations, 1C:lM and 1C:1R
continued to aggregate, while 3:1 sensors remained steady. Figure 2B shows histograms
of the (mass-weighted) particle size distributions exhibited by the 3C:lM sensor in the
presence and absence of calcium; the distributions were calculated from DLS data, as-
suming spherical particle geometry and monomodal but polydisperse distribution of
sizes. The distribution maximum shifts from a radius of roughly 30 nm to a radius near
50 nm when calcium is added, corresponding reasonably with the increase in mean size
reported in panel A.
These DLS results were reinforced by direct visualization of dissociated and aggre-
gated particles using atomic force microscopy (AFM). Figure 2C shows AFM images of
3C:IM binary mixtures (20 mg/L Fe) preincubated for one hour in 50 pM EDTA or 50
pM CaCl 2 solutions before sample preparation. The image obtained in the absence of
calcium (left panel) shows individual nanoparticles and small clusters distributed over the
surface of the mica substrate. In the calcium-containing sample (right panel), the mean
cluster size is significantly larger, though small clusters are still visible. The clusters are
also sparser, due to the fact that a constant number of nanoparticles are now distributed
among fewer aggregates than in the calcium free condition. Similar results were obtained
for 3C:lR (not shown). Note that differences in the precise aggregate size distributions
recorded by DLS and AFM could have arisen because of the altered conditions required
for optimal AFM imaging: higher SPIO concentration and adhesion to mica. Nonethe-
less, both of these techniques clearly indicate that the presence of calcium ions drives
particle clustering and increases the mean size of SPIO aggregates observed after incuba-
tion.
MRI signal changes in response to calcium. SPIO calcium sensors based on
CaM/M13 or CaM/RS20 interactions were investigated by MRI, and extremely robust
calcium-dependent contrast changes were observed. We used a spin echo pulse sequence
with multiecho acquisition to collect images at several echo times in parallel. Figure 3A
shows images of a microtiter plate containing CaM and M 13 conjugates, obtained at echo
times of 10, 20, 40, and 80 ms with this approach, and with an SPIO concentration again
of 7.9 mg/L Fe. The images indicate that the MRI signal from wells containing 3C: 1M is
significantly greater when calcium is present, and that the effect is most pronounced at
longer TE, while still maintaining excellent signal-to-noise ratio. Wells containing buffer
(PBS), CaM conjugates alone, or M13 conjugates alone, show signal that is independent
of calcium; the MRI signal falls off fastest as a function of TE for SA-MACS-CaM, con-
sistent with the fact that the CaM conjugate SPIOs have the smallest mean radius in solu-
tion. Control experiments indicated that the contrast changes were not a function of slice
position, and are thus unlikely to result from settling or precipitation of particles in the
samples for which signal increases were observed (Figure 7).
Figure 3B shows the relative T2-weighted MRI signal observed for all of the mix-
tures we investigated by DLS; this normalized image was obtained by dividing the raw
image intensities observed at 30 ms TE by the signal at 10 ms TE, and removes potential
effects of volume inaccuracies and some sources of MRI sensitivity variation across the
field of view (small effects due to excitation inhomogeneity remain, however). The im-
age shows that all sensor variants display significantly greater MRI signal in 500 pM
CaCl2 than in 500 ptM EDTA. The signal changes observed for 3C: IM and 3C: IR were
greater than those observed for IC:1M and 1C:1R, mainly because the 1:1 mixtures dis-
played relatively large signals in EDTA. These data indicate that calcium sensors pro-
ducing the greatest MRI contrast changes can be formed by mixing CaM and target con-
jugate SPIO populations in an asymmetric ratio. Figure 3C shows T2 values obtained by
fitting exponential curves to the multiecho image data from the samples in panel B. The
values coincide with the imaging results in showing that the greatest MRI changes are
produced by calcium sensors with 3:1 particle ratio, and that the T2 changes by a factor of
2-3 for these sensors under the conditions used.
T2 relaxivity (R2) for each sensor variant in the presence and absence of calcium was
estimated from the data of Figure 3. Figure 4 shows, as discussed above, that R2 is
strongly negatively correlated (r2 = 0.84) with increasing mean diameter up to particle
clusters about three times the diameter of SA-MACS-CaM; at this size, aggregates have
fairly low relaxivity, which remains undiminished for larger aggregates. Residual scatter
in the data may be due to measurement errors as well as variability in the density and
geometry of the different aggregates, which are both predicted to influence relaxivity.
For the 3C: lM sensor, R2 was estimated to be 220 s 1 mM' Fe in the calcium-free condi-
tion, and 45 s 1 mM' Fe in 1 mM CaCl 2; for 3C:lR R2's were 200 and 34 s1 mM-1 Fe in
calcium-free and calcium conditions, respectively. These roughly fivefold relaxivity
changes are significantly greater than the approximately twofold R1 changes reported
elsewhere for TI-based MRI ion sensors.
The data of Figures 3 and 4 indicate that calcium induced clustering of our sensors
corresponds to decreases in T2 relaxivity (producing greater T2-weighted MRI signal), in
contrast to results obtained with smaller mononuclear iron oxides (MION) (28). This
effect was general among variants of our sensor, and could also be produced by calcium-
independent clustering of the SPIOs we used: In the presence of stoichiometric quantities
of polyvalent biotin-dextran, uncomplexed SA-MACS showed a pronounced increase in
hydrodynamic radius and a two- to three-fold decrease in T2 relaxivity (data not shown).
An inverse relationship between iron oxide cluster size and T2 relaxation rates has been
described previously (70), and explained by the extensive theoretical work of Gillis and
colleagues (21-23). For colloidal suspensions of fixed iron oxide volume fraction, the
particle size-dependence of T2 relaxivity depends on the quantity &oR 2/D, where &o is
the change in (angular) NMR frequency at the particle equator, R is the radius of the clus-
ter, and D is the self-diffusion coefficient. For SPIO solutions where dwR 2/D < 1, both
T2 and T2* shorten with increasing R, while for oR2 /D > 1 (sometimes referred to as the
"static dephasing" regime) T2 increases with R and T2* remains roughly constant at a
minimum value. Three arguments support the conclusion that the aggregation-dependent
T2 changes we report correspond to the static dephasing regime: First, our clusters have
average radii over 25 nm, at which moR 2/D is predicted to be 8.1 or greater, based on a D
of 2.3 jtim2/ms and wo of 3.4 x 107 rad/s for magnetite, and assuming that cores are dis-
tributed throughout each particle. Second, we observe a systematic increase in T2 with
increasing cluster size, as diagrammed in Figure 4. Third, we observe negligible differ-
ences in T2* between clustered and dispersed SPIOs (Figure 8), as predicted under static
dephasing conditions.
Time course and reversibility of changes in size and T2 relaxivity. The time
course and reversibility of calcium-dependent SPIO conjugate aggregation were investi-
gated using serial DLS measurements, following manual mixing. Figure 5A shows a
representative series of measurements obtained after dilution of a 3C:1M preincubated
for one hour in 100 gM EDTA into a final concentration of 500 pM CaCl 2 (filled circles).
An increase in average size by 10-20% in the first few tens of seconds (from the starting
value of 1.0) is followed by a slower increase toward the steady-state distribution of hy-
drodynamic radii. In contrast, EDTA-induced disaggregation of clustered particles prein-
cubated in 100 pM CaC12 is significantly faster (open circles), and returns almost com-
pletely back to a relative r of 1.0 within a few seconds. A control dilution of these clus-
tered particles into 100 pM CaCl 2 results in a steady distribution of clusters with the
mean radius indicated by the horizontal gray line in Figure 5A. Similar results were ob-
tained when aggregation and disaggregation of the 3C:IR sensor was studied by DLS.
These data show that the calcium response of CaM-based SPIO aggregation sensors is
initiated quickly and is fully reversible, but that the aggregation process requires consid-
erable time to reach equilibrium.
The time courses of calcium-dependent changes in T2 were measured by MRI fol-
lowing mixing using the same conditions as in Figure 5A. After dilution of 3C: IM sen-
sors from EDTA into 500 gM CaCl2, increases in T2 began immediately and continued
approximately linearly over an hour (filled circles in Figure 5B), corresponding to gradu-
ally decreasing changes in relaxivity over time. When 3C:1M sensors preincubated in
calcium were diluted back into 500 pM EDTA, however, the measured T2 dropped back
to near its initial value within the dead time of the experiment (four minutes) and then
remained roughly constant (open circles in Figure 5B). Similar evolution of T2 during
aggregation and disaggregation was also observed using the 3C:1R sensor. These results
show that changes in T2 , like particle aggregation, are reversible but slow to reach equi-
librium in the presence of elevated calcium.
Calcium detection range and tuning of the sensor. We determined the midpoint
(EC5 o) of the calcium-induced sensor responses by measuring DLS and MRI signals as a
function of calcium concentration. Figure 6A is a representative titration curve showing
intensity-weighted mean DLS radii obtained with the 3C: 1M sensor; the EC50 observed
for this sensor was 1.4 ± 0.1 (n = 3). Samples spanning a range of calcium concentrations
were also imaged by MRI (Figure 6B), using the methods of Figure 3. The MRI signal
and corresponding T2s (Figure 6C) follow the DLS titration curve fairly closely, with an
apparent transition midpoint near 1 ptM Ca 2 . The resting concentration of calcium in
most cells is near 0.1 iM, and ionic influx associated with signal transduction typically
creates local concentrations from 1-10 iM Ca 2 ; the calcium sensitivity of the new re-
agent is well suited to detecting concentration fluctuations near the lower end of this
range.
Manipulating the calcium sensitivity of our SPIO sensors is convenient because of
the ease with which CaM and CaM-target domains can be modified using standard mo-
lecular biology techniques. Figure 6D shows calcium titration curves measured by DLS
for SA-MACS-based calcium sensors formed by conjugating two mutants of recombinant
Xenopus CaM (XCaM) to SPIOs instead of to the wild-type bovine CaM used in the ex-
periments reported above. The solid curve (filled circles) of this figure is data from a 3:1
binary sensor (3X1:1M) made from conjugates with M13 and XCaM E104Q (13), a CaM
mutant with broadened calcium sensitivity (EC50 0.8 ± 0.3 pM, n = 3); the dashed curve
(open circles) is data from an analogous sensor (3X2: lM) formed with an XCaM mutant
(S81R/E83K/E87R/E104Q) further modified to reduce its affinity for the M13 peptide
(71)-because protein complex formation and calcium binding are linked processes, this
variant also exhibits lower calcium affinity (EC5o 10 ± 2 piM, n =2) than 3X1:lM. Both
titration curves for 3X1:iM and 3X2:lM appear to show less cooperative calcium bind-
ing (a gentler sigmoidal transition) than the bovine CaM-based sensor 3C: lM. This is
probably due to the calcium site substitutions present in the CaM variants used in these
sensors. The calcium binding properties of wild-type and mutant CaM proteins affect the
aggregation phenomena we observe via kernels for binary aggregation and fragmentation
events, which in turn depend on the rate constants for intermolecular association and dis-
sociation between CaM and its targets.
MRI scans in Figure 6E and corresponding T2 values in panel F show that the sensi-
tivity changes apparent in the DLS titration curves are also reflected in the calcium de-
pendence of T2 relaxation for these conjugates: T2 changes for the 3X1:iM are again
apparently less cooperative as a function of [Ca2+] than those for wild-type bovine CaM
(panel C), and v changes reported by the 3X2: IM variant begin at higher calcium concen-
trations. The DLS and MRI data from variant sensors therefore show collectively that
appropriate choice of protein mutations can alter either the cooperativity or the EC50 of
calcium binding, optimizing the sensor for reporting in different Ca2+ concentration
ranges. In the future, mutagenesis of the sensor components may also alter the sensor's
propensity to cross-react with endogenous CaM-related proteins in vivo (26).
MRI applications of SPIO-based calcium sensors. The absolute T2 relaxivity and
calcium-dependent T2 relaxivity changes observed for the new SPIO-based sensors are
conducive to applications in MRI studies with less than 5 mg/L (90 pM) Fe present, cor-
responding to particle concentrations on the order of 1 nM, and calcium binding site con-
centrations of 0.2 pM for the 3C:1M or 3C:lR sensors (assuming optimal conjugation
and four Ca sites per CaM). The calcium binding ratio (KB) of sensors at this concen-
tration is therefore approximately 0.2, much lower than the endogenous calcium binding
ratios (Ks ~ 10-1000) typically observed in cells (73). The low quantities of agent re-
quired for MRI-based detection are therefore unlikely to influence endogenous calcium
dynamics, in contrast to typical small molecule calcium sensors (74). On the other hand,
the relatively slow response rates of the SPIO sensors to changes in calcium will not en-
able detection of individual short-lived calcium transients (-50 ms) or fast fluctuations
common to neurons and other signaling cells. Rather, current forms of the sensors may
be appropriate for monitoring integrated calcium levels (0.1-1.0 pM Ca 2 ) that vary over
several minutes, either in response to slow biological events (e.g. calcium waves in de-
veloping embryos) or during relatively long stimulation epochs. To improve the response
kinetics, it will be possible to conjugate the same protein moieties to smaller iron oxide
particles and to vary the conjugation level (72). Signal processing techniques (high-pass
filtering) may also help resolve more rapid components of the sensors' responses to cal-
cium concentration changes during MRI time series.
Intracellular applications of the new SPIO conjugate sensors may initially require
microinjection into cells, but several studies show that strategies for less invasive deliv-
ery could soon be practical (75, 76). Once they are in cells, the sensors still face influ-
ences may that impede their calcium-dependent response properties. First, the proteins
that actuate the agents (CaM, M13, and RS20) could interact with endogenous analogs
whose binding to the sensor competes with particle aggregation. Endogenous CaM is
expected to pose the greatest "threat" in this regard, since its intracellular concentration
can sometimes be greater than 1 pM (77-79). To address this problem, our laboratory has
adopted a mutational approach similar to one used recently to modify fluorescent CaM-
based calcium sensors (71, 80). Second, although the sensors will be targeted to cell cy-
toplasms, it is possible that some may be trapped in endosomes or other compartments
where they cannot function properly. To overcome this barrier, higher concentrations of
the sensor may be required, and calcium-dependent signal changes may be attenuated by
T2 relaxation due to inappropriately localized sensor particles (as well as intrinsic contri-
butions to background T2). Fortunately, because compartmentalized particles often form
aggregates and the aggregated forms of our sensor particles have low T2 relaxivity, their
influence on cellular calcium imaging may be relatively benign. Concentrations well
over 1 nM of the 3C:lM and 3C:IR sensors could also be used if necessary; delivery may
be difficult, but serious calcium buffering is unlikely to occur below 1 pM in calcium
binding sites.
In select cases, useful MRI measurements may be possible with the prototype cal-
cium sensors we present here, but it is clear that significant hurdles must be still con-
fronted in order to apply these contrast agents to a variety of pressing biological prob-
lems. Nevertheless, specific molecular strategies can be used to improve properties of
the sensors, including both their slow kinetics and potential cross-reactivity. The calcium
sensitivity and high relaxivity of CaM/target-conjugated SPIOs will then make them and
their derivatives potent reporters of calcium-related signaling events for functional MRI
studies in vivo.
FIGURE LEGENDS
Figure 1. Calcium sensor mechanism. (A) SA-MACS-CaM (red) and SA-MACS-M13
(green) nanoparticles form binary aggregates in the presence but not the absence of cal-
cium; SPIO aggregation is predicted to lead to T2 changes. (B) The calcium-dependent
interaction of CaM (red) and M13 (green) polypeptides underlies the aggregation effect,
which requires that each nanoparticle be polydentate in one of these proteins. Protein
surfaces are biotinylated (arrows) and attached to SPIOs via tight biotin/streptavidin
binding.
Figure 2. Light scattering and AFM analysis of calcium-dependent behavior. (A)
Mean particle radii are graphed for SA-MACS-CaM, SA-MACS-M13, SA-MACS-RS20,
and binary mixtures. CaM conjugates mixed in 1:1 ratio with M13 and RS20 conjugates
are denoted 1C:lM and LC:lR, respectively; 3:1 ratios are denoted 3C:lM and 3C:lR.
Radii are expressed relative to the radius of SA-MACS-CaM, for each mixture in 500 pM
CaCl2 (grey bars) and in 500 p.M EDTA (white bars). Error bars denote standard errors
of the mean (n = 3). Strong calcium-dependent effects are observed for all mixed SPIO
samples. 1:1 ratios produce the largest aggregates, but also show a tendency toward cal-
cium-independent clustering. 3:1 binary sensors show little aggregation in the EDTA
condition but still display a robust calcium-induced response. (B) Size distributions of
the 3C:lM sensor in 500 p.M EDTA (dotted line) and 500 p.M CaCl 2 (solid line). Distri-
bution histograms were calculated from DLS data assuming polydisperse but monomodal
size populations, and represent the percent mass estimated in each size interval. (C)
Atomic force micrographs of 3C:IM samples obtained after preincubation in 100 pM
EDTA (left panel) or 100 pM CaCl2 (right panel), and indicating a change in clustering.
The scale bar corresponds to 500 nm.
Figure 3. T2 relaxation rate changes measured by MRI. (A) SPIO conjugates were
arrayed into microtiter plates and imaged by MRI. A spin echo pulse sequence was used
with CPMG acquisition to collect images at multiple echo times for each excitation (see
Methods for details). The four images shown here indicate signal dependence on echo
time (TE) for PBS buffer, SA-MACS-CaM, SA-MACS-M13, and a calcium sensor
formed by mixing these two species in a 3:1 ratio, each in the presence either of 500 pM
Ca 2 + ("+") or 500 pM EDTA ("-"). Unmixed CaM conjugates have the highest relaxivity
and produce the most diminished signal at high echo times. The calcium sensor shows
high relaxivity in the absence of calcium but not when calcium is present, where the sig-
nal remaining at 80 ms TE for the sensor is comparable to that observed for PBS alone.
All SPIO solutions contained 7.9 mg/L Fe. (B) Normalized T2-weighted MRI signal ob-
served for PBS, unmixed SPIO conjugates with CaM, M13, and RS20, and for the sensor
variants described in the text: 3C:lM, IC:lM, 3C:lR, and 1C:lR. For each species, the
top row shows signal observed in the presence of 500 ptM CaC12 and the bottom row pre-
sents signal in 500 piM EDTA. This image was calculated by dividing MRI intensities
observed at TE = 30 ms by intensities at TE = 10 ms. (C) T2 values obtained by fitting
monoexponential decay curves to MRI signal as a function of TE (odd echos only: TE =
10, 30, 50, & 70 ms), using the data from panels A and B. For each solution, the T2 ob-
served in the presence (grey) and absence (white) of calcium is reported. Calcium-
dependent T2 changes are greatest for the 3:1 conjugate ratio calcium sensors (3C: IM and
3C:l R).
Figure 4. T2 relaxivity dependence on relative aggregate size. A plot of T2 relaxivity
(R2) versus mean particle size, measured by DLS and expressed relative to the intensity
weighted mean diameter of SA-MACS-CaM. R2 values were calculated using the data of
Figure 3 and the expression R2 = (1/ T2 - 1/ T2PBs)/[Fe], where T2PBS was the measured T2
in PBS (180 ms) and [Fe] was the concentration of nanoparticle iron (7.9 mg/L or 141
pM). Open and closed symbols refer to data points obtained in 500 gM EDTA and 500
pM CaCl2, respectively. Circles refer to unmixed SPIO samples-SA-MACS-CaM, SA-
MACS-M13, or SA-MACS-RS20 alone; squares refer to sensors with 1:1 conjugate ratio,
and triangles refer to sensors with 3:1 conjugate ratio. Particles with relative r up to 3
times the radius of SA-MACS-CaM showed strong negative correlation between size and
R2 (solid line).
Figure 5. Time courses and reversibility of calcium-dependent changes. (A) Repre-
sentative time courses of particle association and dissociation for the 3C: LM aggregation-
based calcium sensor. To measure association (filled circles), 3C:lM mixed particles
were preincubated in 100 pM EDTA for one hour before dilution into a final concentra-
tion of 500 pM CaCl2. To measure dissociation, particles were premixed in 100 pM
CaCl 2 and diluted into 500 pM EDTA (open circles). The horizontal gray line approxi-
mates the starting point for disaggregation, measured by diluting particles preincubated in
100 jM CaCl 2 into the same buffer before DLS. (B) Time courses of changes in T2 re-
laxation time following calcium-induced aggregation and EDTA-induced disaggregation.
Preincubations and dilutions were performed as for the DLS experiments in panel A, but
larger volumes were used. Filled circles correspond to dilution from EDTA into calcium,
and open circles correspond to dilution from CaCl 2 to EDTA. Measurements were taken
continuously over one hour using the methods of Figure 3, with each image requiring
eight minutes to acquire and a mixing and setup dead time of four minutes. The horizon-
tal gray line approximates the initial T2 of disaggregating SPIOs, again measured by con-
trol dilution of particles in 100 pM CaCl2.
Figure 6. Calcium sensitivity range and tuning of calcium sensor variants. (A) Cal-
cium titrations were performed to determine EC5os of the SPIO calcium sensor variants.
EGTA-buffered solutions were used for 0-1.35 ptM and 39 ptM Ca2+ concentrations, and
unbuffered calcium solutions were used for the remainder of concentrations in the 1.5-
500 piM range. The EC50 determined for 3C:IM from three independent titrations (one
shown here) was 1.4 + 0.1 pM Ca2+. (B) A normalized MRI image analogous to Figure
3B showing relative signal obtained from 7.9 mg/L 3C:lM sensor in the presence of 0-
5.0 pM calcium ions. The transition in signal amplitude occurs near 1 jiM, as indicated
by the DLS data. (C) T2 values computed from the MRI data of panel B. (D) Calcium
titration of sensors constructed from mutant Xenopus CaM proteins, 3X 1:1 M (filled cir-
cles) and 3X2: LM (open circles). The mutant CaM used in the 3X2: lM sensor has a
lower affinity for the M13 sequence; coupling between calcium sensitivity and binding
affinity is likely to reduce this variant's calcium binding affinity (EC5o 10 ± 2 pM, n = 2).
(E) MRI signal intensity at calcium concentrations from 0 to 15 pM (TE = 40 ms, nor-
malized as in panel B but with color scale from 0 to 0.8). The 3X1: 1M variant shows
similar behavior to 3C: IM but with more gradual transition in intensity with increasing
[Ca2+], as in the DLS titration curve. Variant 3X2:1 M shows transition onset at higher
calcium concentration and even at 15 pM Ca2+ has not apparently reached a saturated
response. (F) T2 values computed from the image data of panel E, for sensor variants
3X1:1M (filled circles) and 3X2:1M (open circles).
Figure 7. Equivalence of T2 values measured at different positions in a microtiter
plate. (A) SPIO samples in 500 pM EDTA (-) and 500 pM CaCl2 (+) were arrayed in a
microtiter plate as in Figure 3. Each well contained 80 pL of solution, with a total depth
of 5 mm. Two adjacent 2 mm slices were imaged through the plate, to determine whether
any evidence of particle settling (precipitation) could be observed. Left and right panels
show contrast visible in the upper and lower slices, respectively (TE = 40 ms); little dif-
ference is distinguishable. Contrast differences between this panel and the data of Figure
3 reflect sample preparation to preparation variability, which was minor for RS20-based
sensors, but noticeable for some M13-containing conjugates. (B) T2 values were com-
puted from the upper and lower slices of panel A and plotted against each other to indi-
cate the level of correlation. A correlation coefficient of 1.00 was obtained, with a linear
regression (solid line) close to direct y = x equivalence (dotted line). T2 values measured
for the lower slice were slightly longer on average than values measured in the upper
slice. This is the opposite to the trend one would predict assuming sedimentation of the
SPIOs, and may reflect a combination of bulk susceptibility and shimming influences on
these measurements. We therefore conclude that sedimentation of SPIOs does not sig-
nificantly influence the findings of this manuscript. The symbols used here correspond to
the convention of Figure 4: Open and closed symbols refer to data points obtained in 500
gM EDTA and 500 pM CaCl2, respectively. Circles refer to unmixed SPIO samples-
SA-MACS-CaM, SA-MACS-M13, or SA-MACS-RS20 alone; squares refer to sensors
with 1:1 conjugate ratio, and triangles refer to sensors with 3:1 conjugate ratio.
Figure 8. T2 * measurements obtained from SPIO solutions. (A) A microtiter plate
containing arrayed samples was prepared as in Figures 3 and Si. Images were obtained
using a standard gradient echo pulse sequence with echo times of 5, 10, 20, and 40 ms, by
which point little signal remained. The images showed marginal contrast between CaC12
(+) and EDTA (-) conditions (TE = 20 ms displayed here). (B) T2 * values were estimated
by fitting exponential decays to the data of panel A. Little variation among these relaxa-
tion rates was observed across the samples, and no systematic difference could be de-
tected between calcium (gray) and EDTA (white) conditions. Measured T2 * values clus-
tered near a mean of 18 ms (std. dev. = 2 ms). This value is near the lowest recorded T2
for any of these samples (20 ms for CaM-SA-MACS), and is therefore consistent with the
predictions of static dephasing theory.
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3. MRI Calcium Sensors Based on Crosslinked Lipid-Coated Iron Oxide
Nanoparticles
The research described in this chapter has not been published yet, but will serve as a
foundation of a future paper. Previously, we have introduced a new family of calcium
indicators for magnetic resonance imaging (MRI), formed by combining a powerful iron
oxide nanoparticle-based contrast mechanism with the versatile calcium sensing protein
calmodulin and its targets. These sensors display some limitations, such as relatively slow
kinetic response to elevated calcium and slow diffusivity. Here we use small lipid coated
iron oxide nanoparticles (LCIOs) as a basis for the second generation of our contrast
agents in order to overcome some of these problems. Sensors formed using LCIOs ex-
hibit similar dramatic changes in T2 relaxation rates upon aggregation induced by cal-
cium. The lipid coatings could be stabilized by using a UV-crosslinking strategy, and
permitted an exceptionally high density of protein conjugation-a key determinant of
sensor response kinetics. Preliminary results show that calcium sensors formed with
these particles show favorable size distributions and robust calcium-dependent aggrega-
tion properties.
INTRODUCTION
We have previously introduced a potent, tunable MRI calcium-sensitive contrast
agent that was based on conjugation of the calcium sensing protein calmodulin and its
target peptides (M13 and RS20) to superparamagnetic iron oxide nanoparticles (81, 82).
Binding of the CaM and target peptide drives particle aggregation and produces a dra-
matic change in the T2 relaxivity. Calcium sensing is reversible and occurs around a
midpoint of 1 pM Ca 2 , which could make this sensor appropriate for imaging of cytoso-
lic calcium fluctuations in cells. There are some limitations that need to be overcome in
order to use this sensor in vivo, such as its relatively slow kinetic response to elevated
calcium and slow diffusivity. Small lipid coated nanoparticles (LCIOs), synthesized by
coating iron oxide cores with functionalized polyethyleneglycol (PEG) lipids are utilized
as the basis for the second generation of our sensors that may overcome some of these
issues (83). Because of their small size (~ 15 nm in diameter) relative to other SPIO con-
trast agents (usually 30-200 nm), these LCIOs will be particularly useful for applications
requiring delivery and mobility inside cells (characteristic dimensions 1-100 jIm) or dif-
fusion in the brain interstitium (< 1 pm width). LCIO nanoparticles have additional ad-
vantages, such ease of synthesis, water stability, chemical multifunctionality, achieved by
mixing different lipid species, and extraordinarily high conjugation density, a characteris-
tic we identified as required for fast sensor responses (31).
Here we present our work on developing calcium sensitive contrast agents based on
LCIOs. Since LCIOs display some instability, we introduce a novel type of LCIOs, with
coating lipids contain diyne groups that can be cross-linked by exposure to UV light. The
crosslinked lipid coated iron oxide nanoparticles (xLCIOs) are much more stable than
conventional LCIOs. They are conjugated to CaM and RS20 to form the next generation
of our calcium sensor, which may be useful for future measurements of fluctuations of
calcium in vivo.
MATERIALS & METHODS
Preparation of LCIOs. Superparamagnetic iron oxide (y-Fe304) nanoparticles
capped with oleic acid and dispersed in toluene were kindly provided by Numpon Insin,
MIT. 1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine-N-[Maleimide(Polyethylene
Glycol)2000] (DSPE-PEG(2000) Maleimide) and 1,2-Distearoyl-sn-Glycero-3-
Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-2000] (DSPE-mPEG(2000)) in
lyophilized form were purchased from Avanti Polar Lipids ( Huntsville, AL) and dis-
solved in chloroform . Iron cores and mixtures of phospholipids of 10:1 ratio of DSPE-
PEG(2000)Maleimide to DSPE-mPEG(2000) were combined in multiple 500 pl aliquots
in such a way that the final concentration of cores was 0.4 mg/ml and of the lipid mixture
2 mg/ml. These mixtures were incubated for two hours at room temperature and dried
overnight in Speedvac in order to remove the organic solvents. The dried pellets were
resuspended in 500 d of deionized water. Clear solutions with no precipitate were char-
acteristic of successful coating procedure. The newly formed LCIOs were filtered using
inorganic 0.1 ptm Anotop inorganic membrane syringe filters (Whatman, UK). Maleim-
ide groups on the surface of the particles were quantified using ultrasensitive thiol and
sulfide quantification kit from Molecular Probes (Eugene, OR).
Preparation of xLCIOs. In order to prepare more stable small nanoparticles 1,2-
bis(10,12-tricosadiynoyl)-sn-glycero-2-phosphoethanolamine-N-
[Maleimide(Polyethylene Glycol)2000] (23:2 Diyne PE-PEG(2000) Maleimide) ob-
tained from Avanti was used for coating. The procedure was equivalent to that for the
LCIOs, other than the pure 23:2 Diyne PE-PEG(2000) Maleimide was used in final con-
centration of 2.4 mg/ml. The sample containers were wrapped in aluminum foil in order
to protect them from light exposure. After filtration, the sample solutions were flushed
with argon in order to remove dissolved oxygen from the solvent. The crosslinking of the
nanoparticles coating was performed by exposure to ultraviolet (UV) light of 254 nm
wavelength for 40 minutes in a 1 mm quartz cell at 10 cm distance from the UV lamp.
Control reaction was done by exposing the samples in quartz cells wrapped in aluminum
foil to UV light under same conditions. UV-visible spectroscopy was used to follow the
time-course of the photocrosslinking reaction.
Transmission electron microscopy. Transmission electron microscopy (TEM) was
performed using a JEOL 200CX general purpose transmission electron microscope at
50,000x magnification. 5 pl of LCIO solution was pipetted onto ultrathin carbon grid
(Ted Pella, Redding CA), and then 5 pl of 2 % phosphotungstic acid was added and in-
cubated for 2 minutes for negative staining. The liquid was subsequently removed and the
grids were imaged. In order to optimize sample loading onto the carbon grids, LCIO
concentrations used for these experiments were 10 times higher than for DLS experi-
ments.
Protein and peptide synthesis. Cys-RS20 was synthesized by standard Fmoc chemistry;
cysteine was added as the N-terminal residue, spaced by a glycylglycine linker, such that
the full sequence was CGGRRKWQKTGHAVRAIGRLSSS. The peptide was purified
by standard C18 reversed-phase high pressure liquid chromatography, assayed by mass
spectrometry, and stored in phosphate-buffered saline (PBS), pH 7.2, at 4 'C for up to
two days only, because of the fast oxidation of the terminal cysteine residue. Expression
vector for recombinant CaM was derived from a Xenopus CaM gene (XCaM E104Q)
generously provided by Atsushi Miyawaki. Standard molecular biology techniques were
used to modify the gene with coding sequences for a hexahistidine tag and a free cysteine
near the N-terminus; sequencing of the clone also indicated presence of the nonstandard
substitution D64Y. Recombinant XCaM was expressed in E. coli and purified using
nickel-affinity chromatography and FPLC. Expressed protein was assayed by SDS poly-
acrylamide gel electrophoresis and mass spectrometry, and stored in PBS, pH 7.2, at 4 'C
for up to two days. For peptide and protein concentration determination extinction coef-
ficients at k=280 nm of 5500 M-' cm' and 9000 M-' cm', respectively, were used. Ell-
man's reagent (5.5'-Dithiobis(2-nitrobenzoic acid)), purchased from Sigma (St. Louis,
MO), was used for measurement of the free sulfhydryl content in the protein and the
peptide. This determination is based on the colorimetric assay which measures A412 of the
polypeptide solutions after reaction with Ellman's reagent and uses the extinction coeffi-
cient for the 2-nitro-5-thiobenzoate anion (which gives an intense yellow color) of 14150
M-1 -1"M_ cm-
Formation of conjugates. To form conjugates, XCaM and RS20 containing an N-
terminal cysteine were mixed with LCIOs or xLCIOs in two to five fold excess over their
malemide content. The total reaction volume was 0.5 ml. The mixtures were incubated in
PBS, pH=7.2 for 2 hours at room temperature. After that, excess free cysteine was added
in order to bind any free maleimide group and incubated for another 30 minutes. Unre-
acted polypeptides were purified away from the nanoparticles by dialysis into 2 liters of
10 % PBS using medium sized Tube-O-Dialyzer vials with a molecular weight cutoff of
50,000 Da from G-Biosciences (Maryland Heights, MO). The amounted of conjugated
polypeptides was quantified using their UV absorption at 280 nm as well as Bio-Rad
(Hercules, CA) protein assay based on the Bradford method.
Light scattering experiments. Dynamic light scattering (DLS) measurements
were performed using a DynaPro DLS system (Wyatt Technology, Santa Barbara, CA) at
25 0C. For each sample or condition, a single intensity weighted value was used to char-
acterize the average size of all particles in the specimen. Most DLS measurements were
obtained after 30 minutes of incubation in the reported buffer condition, with 120-fold
averaging and a one second integration time.
Magnetic resonance imaging. Imaging was performed on a 40 cm bore Bruker
(Billerica, MA) Avance 4.7 T scanner equipped with 26 G/cm triple-axis gradients, and
using a 10 cm birdcage coil (Bruker) for radiofrequency transmission and detection.
Samples (80 pil) were arrayed into microtiter plates, sealed with plastic adhesive covers,
and loaded onto a plastic tray in the imaging probe. Unused wells of each plate were
filled with PBS in order to minimize susceptibility-related distortions in the MRI. Imag-
ing was performed on a 2 mm slice selected at the middle of each microtiter plate well
(parallel to the plate). A T2-weighted multi slice multi echo (MSME) pulse sequence was
used, with acquisition of eight two-dimensional echo images per excitation. Repetition
time (TR) was 2 s and echo time (TE) ranged from 10 ms to 80 ms, in 10 ms increments.
Data were acquired as matrices of 512 x 128 points for each echo image and zero-filled to
256 points in the second (phase encoding) dimension. Images were reconstructed and
analyzed using custom routines running in Matlab (Mathworks, Natick, MA). Relaxation
rates and relaxivities reported in the text were calculated by exponential fitting to the
image data.
RESULTS & DISCUSSION
Magnetic iron oxide particles (Fe 30 4) are typically synthesized in organic phase, in
our case using oleic acid capping method (84). In order to make the particles water solu-
ble and biocompatible, we have encapsulated them in a micelle structure that consists of
PEG-modified phospholipids. Since PEG-phospholipids are amphiphilic molecules, their
hydrophobic components (phospholipid) can interact directly with iron oxide nanoparti-
cles, while the hydrophilic PEG moieties extend away from the superparamagnetic core
into the aqueous solution. If appropriately modified PEGs are used, this allows for the
conjugation of various biomolecules, such as proteins. In this work, PEG-phospholipids
with functional maleimide groups are utilized for nanoparticle coating, in order to take
advantage of the maleimide-thiol coupling chemistry. The size distribution of the parti-
cles was characterized using both dynamic light scattering (DLS) and transmission elec-
tron microscopy (TEM) and it was found that the average particle diameter was ~ 15nm,
which implies that the average coating thickness is ~ 4nm (Figure 1). T2 relaxivity of
LCIOs was determined to be of 160 s-1 mM-' Fe at 4.7 T. Unlike larger SPIOs, these
particles also have measurable T, relaxivity of 4.5 s-1 mM-I Fe at the same magnetic field
strength. Maleimide groups on the surface of the particles were quantified using an ultra-
sensitive colorimetric assay for quantification of protein thiols. In this assay, maleimide
groups were first reacted with a known excess quantity of cysteine to produce thiols in
detectable concentration. These sulfhydryls groups reduce a disulfide-inhibited derivative
of papain, stoichiometrically releasing the active enzyme. The activity of the enzyme is
then measured using the chromogenic papain substrate N-benzoyl-L-argining, p-
nitroanilide (L-BAPNA). We found that the amount of these functional groups available
for conjugation was 50 pM at OD450=0.1, which corresponds to iron concentration of
3.5 mg/liter. This is about three orders of magnitude greater than that of the commercial
SPIO particles used in a previous study. Maleimide coated LCIOs were modified with
CaM and RS20 variants modified to contain N-terminal cysteines. Excess unreacted
polypeptides were purified away from the nanoparticles by dialyzing the conjugates
against 2 liters of 10 % PBS using medium sized Tube-O-Dialyzer vials with a molecu-
lar weight cutoff of 50,000 Da.
Binary sensors were constituted by mixing different ratios of CaM-LCIOs and
RS20-LCIOs in PBS with either 500 pM CaCl2 or 500 pM EDTA. The ratios of CaM-
LCIOs to RS20-LCIPOs that were explored were 3:1, 2:1, 1:1, 1:2 and 1:3. The total
concentration of LCIOs was 1.75 mg/liter Fe. Their calcium-dependent aggregation was
studied using both DLS (data not shown) and MRI (Figure 2). We found that the sensors
showed a significant increase in relative radius in the presence of CaCl 2, compared with
calcium free condition. We found that aggregation was extremely sensitive to the conju-
gation density of the individual particles as well as the ratio of the two types of particles
in the binary mixture. MRI was performed using a spin echo pulse sequence with
miltiecho acquisition to collect images at several echo times in parallel. Figure 2 shows
T2 relaxation rates of CAM-LCIO, RS20-LCIOS and sensor formed my mixing these two
species (CeR) in the presence of 500 pM EDTA (white bars, -) or 500 pM CaCl 2 (grey
bars, +). Large, approximately three fold changes in T2 relaxation rates upon calcium
induced clustering were measured. Figure inset displays a T2-weighted MRI image of the
samples described above. Aggregation of CaM- and RS20-LCIO conjugates caused T2
shortening, as expected for particles small enough (< 20 nm diameter) to produce T2 re-
laxation in the so-called motional averaging regime, but opposite to the larger particles
(-50 nm) used to synthesize the prototype calcium sensors we previously described.
Because individual lipid molecules are not covalently attached to LCIOs, a draw-
back of forming MRI sensors based on LCIO conjugates is the potential for individual
functionalized lipids to dissociate, and therefore for the sensors to display altered proper-
ties over time. With LCIOs formed from disteroyl lipids, we found evidence consistent
with this mechanism: First, we observed that after prolonged incubation in calcium, the
aggregated CaM/RS20-LCIO network spontaneously dissociated. Second, we saw that
incubation in EDTA inhibited aggregation behavior of CaM-LCIO and RS20-LCIO mix-
tures, consistent with the possibility that EDTA competes with labile lipids for interac-
tions on the surface of the iron oxide LCIO cores (Figure 3).
In order to overcome this problem, we therefore resynthesized the particles using
lipids that incorporate diacetylene groups which can be photocrosslinked by exposure to
ultraviolet (UV) irradiation (Figure 4A). The particles were coated with 23:2 diyne pho-
spahatidylethanolamine-PEG(2000) maleimide in the manner described above. After
their dissolution in water, the solution was flushed with argon to remove dissolved oxy-
gen and exposed to UV light of 254 nm wavelength. UV-visible spectroscopy was used
to follow the time-course of the photocrosslinking reaction (Figure 4B). Calcium sensors
were formed from these crosslinked lipid coated nanoparticles (xLCIOs) in an equivalent
manner as with LCIOs. DLS measurements confirmed the sensitivity of the binary sen-
sor size to calcium (Figure 5). Large changes of average radii were observed for a couple
of different ratios of the protein- and peptide-conjugated xLCIOs in the mixtures in the
presence of calcium (red bars). The biggest change was observed from the sensor pre-
pared in 1:1 ratio of CaM-xLCIO and RS20-xLCIAO. xLCIOs displayed vastly im-
proved stability over LCIOs synthesized with non-crosslinkable lipids. The aggregates
remained stable for at least two hours and no undesirable effects were observed after
longer EDTA incubations.
We have successfully synthesized stable, very small LCIOs that will be used for a
new generation of calcium sensitive MRI contrast agents. The two main motives behind
this work were to improve the diffusivity and kinetic response of our sensors. It is possi-
ble that further refinements will be required to improve the response times, such as
loosely crosslinking ensembles of particles using long flexible polymer chains.
FIGURE LEGENDS
Figure 1. Size characterization of LCIOs. (A) Transmission electron micrograph
of LCIOs in negative stain showing mean particle diameters of ~ 15 nm (scale bar is 20
nm). (B) LCIO size distribution (% mass vs. hydrodynamic radius of particles) measured
using dynamic light scattering. Distribution histogram is centered on the radius of 10 nm.
Figure 2. MRI characterization of LCIO-based calcium sensors. LCIOs conju-
gated to CaM and RS20, and sensors formed by mixing the two species (COR) were ana-
lyzed by T2-weighted MRI in the presence of 500 tM EDTA (white bars, -) or 500 jiM
CaCl 2 (grey bars, +). T2 relaxation and image intensity (inset) were consistent with the
aggregation mechanism and size of LCIOs. Large T2 decrease and image darkening upon
calcium induced aggregation were observed.
Figure 3. Instability of the LCIO aggregates. (A) DLS measurement of the ag-
gregate size (red circles) and scattered light intensity (blue circles) as a function of time.
After ~ 30 min the aggregated network spontaneously dissociated. (B) Maximum radii
measured with DLS of the binary sensor after preincubation with a chelator and subse-
quent dilution into 500 ptM CaCl 2 as a function of preincubation time. The red line corre-
sponds to preincubation in 100 piM EFDTA, blue one to 10 piM EDTA, purple one to 1
piM EDTA and green one to 100 piM EGTA. Only for preincubation times shorter than 5
minuted did the aggregates reach expected sizes.
Figure 4. Crosslinked lipid coated iron oxide nanoparticles. (A) Iron oxide
cores are enclosed in a densely functionalizable micelle of 23:2 diyne phospahatidyletha-
nolamine-PEG(2000)maleimide. UV irradiation cross-links the diacetylene-containing
phospholipids to stabilize the LCIO coating as shown on the right; maleimide groups
allow subsequent conkuhation to sulthydryl-containing protein domains. (B) Signatures
of phospholipid cross-linking are detected by UV-visible spectroscopy. Absorbance of
unirradiated LCIOs is due primarily to iron oxide.
Figure 5. Light scattering analysis of the calcium-dependent behavior of
xLCIOs conjugates. Mean particle radii are graphed for CaM-xLCIO, RS20-LCIO and
binary mixtures of these two species in ratios denoted on the graph. The radii are ex-
pressed relative to that of CaM-xLCIAO for each mixture in the presence of 500 pM
EDTA (blue bars) or 500 pM CaCl 2 (red bars). The biggest aggregation effect was ob-
served for the 1:1 mixing ratio.
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4. CONCLUSIONS AND FUTURE DIRECTIONS
This thesis has described a new type of calcium sensitive contrast agents for MRI
based on the conjugation of superparamagnetic iron oxide nanoparticles to calcium sens-
ing protein calmodulin and its target peptides M13 and RS20. The sensors are based on
dramatic, reversible changes of T2 relaxivity upon calcium dependent aggregation of the
particles. A variant of the sensor responds to calcium changes around 1 IM and might be
suitable for detection of elevated intracellular calcium levels. The response and coopera-
tivity of the calcium response can be tuned by mutating the proteins that constitute the
sensors.
There are a couple of limitations for the use of these types of sensors in vivo that
need to be overcome in future work. First, the kinetic response of the sensor is too slow
compared to typical neuronal calcium fluctuation times. Second, large nanoparticle sen-
sors may diffuse ineffectively through the cytoplasm of the cells. In order to improve
both of these, we have synthesized xLCIOs which are much smaller than commercial
SPIOs and have much higher conjugation density, both of which should improve the
characteristic time constant of the aggregation. The much smaller size should result in
more efficient diffusivity as well. Sensors based on xLCIOs have been constructed and
demonstrated to sense calcium in vitro. Further modifications of the sensors, such as
loose crosslinking of ensembles of particles using long flexible polymer chains, might be
needed to achieve desired kinetic properties. Third, there is a potential for the binding of
the constituents of this sensor to endogenous CaM, which is typically present in cells in
concentrations on the order of~ 5 pM, and to the endogenous peptide sequences of M13
and RS20. To address this, work has been undertaken to redesign CaM and M13 in order
to produce mutants that interact with each other much stronger than with the endogenous
variants (71).
Delivery of these sensors to neurons will present another challenge. It has been re-
ported that conjugation of the cell penetratating peptides (CPPs), such as poly-D-arginine
and Tat, to nanoparticles promotes their uptake inside the cells (60). CPPs may be con-
jugated to xLCIOs in order to achieve such effect.
Another direction of this project would be to produce equivalent sensors for the
sensing of extracellular calcium. Since extracellular calcium fluctuates in the range of
0.8-1.2 mM, a sensor with an EC50 point of around 1 mM would be suitable for this pur-
pose. In order to achieve this goal, calmodulin will be mutated in order to decrease its
affinity for calcium. A couple of calmodulin mutants with potentially desirable calcium
affinities have been identified and produced: D133E (85), which has been reported to
reduce the affinity of the site 4 from 1 pM to 2.76 mM; E140Q (86), which reduces the
affinity of the same calcium binding site to 700 pM and E104A. The advantage of this
type of calcium sensor would be to circumvent the need for the cellular delivery of SPIO-
based contrast agents.
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Appendix A
Dynamic imaging with MRI contrast agents: quantitative considera-
tions
Time-resolved MRI has had enormous impact in cognitive science, and may be-
come a significant tool in basic biological research with the application of new molecular
imaging agents. Here we examine the temporal characteristics of MRI contrast agents
that could be used in dynamic studies. We consider "smart" (responsive) T, contrast
agents and T2 agents based on reversible aggregation of superparamagnetic nanoparti-
cles,. We discuss response properties of several agents with reference to available ex-
perimental data, and we develop a new theoretical model that predicts the response rates
and relaxivity changes of aggregation-based sensors. Our analysis confirms that some
small T1 agents may be compatible with MRI temporal resolution on the order of 100 ms.
Nanoparticle aggregation T2 sensors are applicable at much lower concentrations, but are
likely to respond on a single second or slower time scale.
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INTRODUCTION
Many of life's most important processes occur within a fraction of a second. With
temporal and spatial resolution orders of magnitude cruder than optical imaging, MRI
seems a deeply insufficient tool for investigation of this "short-timescale physiology."
But with opaque specimens, noninvasive imaging with MRI may still be a uniquely valu-
able approach. Echo planar pulse sequences allow images to be collected in tens of milli-
seconds-fast enough to freeze-frame the beating heart or record rapid fluctuations of
blood flow in the brain (1). In many other contexts, the limitation on MRI has not been
its intrinsic acquisition rate, but rather the absence of contrast mechanisms that can trans-
late biological events of interest into MRI-detectable signal changes.
Newly developed contrast agents, products of the growing field of molecular imag-
ing, are beginning to change this situation (2, 3). Several groups have introduced agents
useful for mapping static or slowly varying patterns of gene expression and epitope dis-
tribution (4-7). Contrast agents have also been developed for sensing more dynamic
variables such as pH (8-10) oxygen tension (pO2) (11, 12), ion and metabolite concentra-
tions, (13-15) and enzyme-catalyzed reactions (5, 16). These agents have been referred
to as "smart" contrast agents, and function as sensors in MRI, analogous to fluorescent
probes used in optical imaging and microscopy. Some MRI sensors could in principle be
applied to study fast (generally cellular) physiological events, for example: endocytic pH
changes during vesicle recycling on the one second time scale, calcium signaling tran-
sients lasting 10-100 Ms, PO2 fluctuations within 2 s of modulations to oxidative metabo-
lism, and changes in protein phosphorylation in seconds to minutes during neuronal syn-
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aptic plasticity. In each case, however, the practical time resolution attainable with con-
trast agent-enhanced MRI may be limited by the agent's molecular properties and by the
physical requirements of contrast generation.
To be useful for dynamic imaging studies, an MRI sensor must produce a fast
and large enough signal change to be detected on the desired timescale. Although the
steady-state detection thresholds for various contrast agents have been discussed exten-
sively in the literature (e.g. (17-20)), the interaction between sensitivity and dynamics has
been less thoroughly examined. At the same time, a systematic analysis of advantages
and disadvantages of available contrast mechanisms is essential to the development of
effective strategies for fast-timescale molecular imaging. In this paper, we review the
molecular mechanisms of some paradigmatic smart T1- and T2-contrast agents, and con-
sider the agents' response rates using a combination of simulations and reference to exist-
ing experimental data. Throughout this work, we estimate the temporal resolution of
each molecular imaging strategy as the inverse of the duration of the impulse response
that relates an underlying stimulus or change in conditions, to a detectable signal change.
MATERIALS & METHODS
SPIO aggregation simulations
SPIO aggregation and disaggregation were simulated using the Euler method, ap-
plied to the Smoluchowski equation [see Eq. (16) below], which describes the transition
rates among single particles and aggregates of all allowable sizes. The aggregation ker-
nel Kagg, adapted from Odriozola et al. (21), describes the rate constant for binding of two
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aggregates of compositions (i, j) and (k, m) as a function of their diffusion-limited colli-
sion rate and their probability of sticking upon collision:
Kagg(i,j,k,m) = kd, (i,j, k, m) Pstick(ij, k, m)(i + iXk + in)
1 + P,,,c,(ij,k, m)([(i + j)(k + m)] -1I
where sand b correspond to Odriozola's constants N 1 and b, respectively, with respective
values of 6.1 and 0.35. kdl(i, j, k, m) is the diffusion-limited collision rate due to
Brownian motion, given by:
kd,(i,j,k,m)= 2kT [i+ j] + m]ldfX [i+ j] "4 + [k + m] (2)
where kB is the Boltzmann constant, T is the absolute temperature, ri is the medium vis-
cosity and df is the fractal dimension of the aggregates (assumed to be constant through-
out aggregation). Pstick(i, j, k, m) is the sticking probability of the two aggregates, given
by:
PPi[ N - m + km j3Ptic(i, j,k,m) = P N, . N,,, + Nk Nj. .jJ (3)
where Nx for x=i,j,k,m represents the fraction of functional groups of the corresponding
type available for binding, e.g.:
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N. (fV 1)i-j+1 (4)
fi
where f is the number of functional groups per particle and (i, j) is the aggregate compo-
sition. P, is the sticking probability for a collision of two oppositely-functionalized
monomers, which we estimated by assuming cubical geometry for the two types of func-
tional groups, with sides of length da and db and calculating the fraction of the particle
surface that is covered by the functional group (for given functionalization ratios f and g
and particle radius r). The product of these surface fractions is then multiplied by the
bimolecular sticking probability Pbm for free functional groups in solution, which may be
roughly estimated as the ratio of their known binding on-rate kon and their theoretical
diffusion-limited collision rate. We include an additional factor of 6 to account for an
assumption that the cubic functional groups are optimally oriented on the particle surface.
The resulting expression is:
P It= Pb 6d 6gd 2  (5)4rr2 42)
The fragmentation kernel Kfrag, adapted from Laurenzi and Diamond (22), describes
the rate constant of fragmentation of an aggregate of composition (i + k, j + m) into two
aggregates (i, j) and (k, m):
Kfg(ij,k,m) = kff [Af,(ij)Ag(k,m) + Af(k,m)Ag(i)]N(i~j)Ns(k,km) (6)
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Here, koff is the bimolecular dissociation rate for the complimentary functional groups. Af
and Ag are the number of free functional groups of the two types in aggregates of a given
composition, i.e.:
Af(i,j)=(f -)i- j+1; Ag(i,j)=(g-1)j- i+1 (7)
Niso is a combinatorial factor describing the number of possible arrangements of particles
in an aggregate of a given composition:
f'g'(fi - i)!(gj - j)!N,S( (i,j)= (8)
"[Af (ij)) [Ag(ij))iP j!
In order to minimize the computational cost of our simulation, we imposed an upper
limit on the allowed aggregate size, C (z, z), with z = 45. This limit allowed the kernels to
be pre-defined, greatly speeding up the simulations. Under simulation conditions that
favor extensive aggregation, this limit causes an underestimation of average particle size
and an accumulation, or "bunching", of the aggregate population at sizes near the maxi-
mum. However, the parameters used in most of our runs produced aggregates with aver-
age sizes well below this upper limit, and resulting size distributions that did not exhibit
significant bunching. When noticeable bunching did occur, it produced only a minimal
effect on simulation time courses (below 5% for Tobs), with "saturating" effects on
steady-state size evident only when this size approached 2z.
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Unless otherwise noted in the main text, the parameters used in our aggregation
simulations were as follows: ko, = 106 M-1 s-', kot = 6 x 10-4 s~1, f = 50, g = 50, r = 15
nm, df = 2.2, T = 300 K, qi = 1 cp, R2 (non-aggregated relaxivity) = 20 (mM Fe)-I s-1, Fe
atoms per particle = 2064. The same equations and parameters were used to simulate
disaggregation, but with a factor of 102 decrease in kon and a factor of 102 increase in koff.
RESULTS & DISCUSSION
Dynamic imaging with smart T1 contrast agents
T, contrast agents are typically organic complexes containing a paramagnetic metal
ion such as gadolinium (Gd), which strongly promote the relaxation of the water protons
due to the influence of unpaired electron spins of the metal ion. Factors that are impor-
tant in determining the relaxivity of a contrast agent (reviewed in (23, 24)) are contained
in the Solomon-Bloembergen-Morgan (SBM) equations; these include timescales for
various molecular motions, structural features of the contrast agent, and spin properties of
the paramagnetic metal ion. Some of these properties can be manipulated in such a way
as to produce a change in relaxivity coupled to specific events. Among them are the co-
ordination number of the water molecules, q, the lifetime of the water molecule in the
complex, Tm, and the rotational correlation time of the whole complex, TUR. If one of
these parameters differs significantly between two "states" or conformations of a contrast
agent, the intensity of the signal observed with MRI is also changed. The timescale on
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which the change occurs is strongly dependent on the type of the contrast agent and
which property has been affected.
The best explored class of Ti contrast agents relies on the change in solvent expo-
sure to the paramagnetic metal ion (25). The resting state of the contrast agent usually
has relatively low relaxivity, with limited water access to the metal ion. The contrast
agent is switched into a state of higher relaxivity by a biochemical trigger, such as the
activity of an enzyme or a spike in concentration of an intracellular messenger. Several
agents that work by this type of mechanism have been reported in the literature. Louie et
al. (5) synthesized a caged contrast agent called EgadMe, which is a substrate for the en-
zyme P-galactosidase. The activity of p-galactosidase uncages the agent by cleaving a
galactopyranosyl group, exposing a Gd coordination site to raise the agent's effective q
from 0.65 to 1.02; this structural change in turn gives rise to an increase in T1 relaxivity
from 0.903 to 2.72 mM' s 1 (measured at 11.7 T). Like many enzymes, f-galactosidase
obeys so-called Michaelis-Menten kinetics, meaning that the rate of product formation
depends on parameters kcat and Kmin the following equation:
V kcat[E]O[S]
Km + [S]
where [E]o is the total enzyme concentration, [S] is the substrate (caged contrast agent)
concentration, and V is the rate of uncaged product formation in moles per second. The
cleavage of EgadMe takes place with a kcat of 2.4 x 10-3 nmol U-1 s 1 and a Km of 0.0182
mM; this means for example that a 100 pM concentration of the agent would require on
the order of several minutes to be cleaved by 100 U/mL (~ 1 pM) of P-galactosidase.
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Enzymes most likely to be useful for activating contrast agents are those that cleave car-
bon-carbon, carbon-nitrogen, or carbon-oxygen bonds; these typically have a kcat signifi-
cantly smaller than 1 s-I, and are therefore likely to process their substrates over time
scales much longer than the TR of a typical Ti-weighted imaging sequence. In these
cases, the temporal resolution of the method would be limited by the enzyme activity
level, although with large enough enzyme and substrate concentrations the onset of en-
zyme activity might be recognized with TR-limited precision.
Faster relaxivity changes are likely to be produced by ion-sensing MRI contrast
agents. Sensors for calcium and for zinc have been produced (13, 14); as with EgadMe,
they respond to their targets with conformational changes that expose a bound gadolin-
ium atom to water. T, relaxivity changes from 3.26 to 5.76 mM-1 s4 (11.7 T), and from 4
to 6 mM-1 s4 (7 T), for the calcium and zinc sensors, respectively. No kinetic data is
available for either of these contrast agents, but because their mechanisms are somewhat
similar to small fluorescent ion sensors, the response rates of these sensors may be rele-
vant. In particular, the calcium sensitive agent synthesized by Li et al. has similar affinity
and calcium-liganding groups to Fura-2 and related BAPTA-based "fast" calcium sen-
sors. These dyes have measured kin for calcium on the order of 109 M- s- (26). Assum-
ing an MRI calcium sensor had an equivalent kn and a Kd of 1 pM, and if it was used at a
concentration of 100 pM to detect (buffered) calcium concentration fluctuations between
0.1 and 2 pM, its overall response rate would be limited by dissociation, and would likely
be close to a millisecond. This rate is two orders of magnitude below practical TR val-
ues. Time resolution in imaging experiments using MRI ion sensors would therefore be
determined by the repetition rate of the imaging procedure.
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Another method shown to enhance the relaxivity of a Ti contrast agent is to in-
crease its rotational correlation time, TR. For small molecules, TR dominates the total cor-
relation time (Tc), a parameter that enters into the SBM equations and strongly influences
the magnetic field dependence of TI relaxivity. Since
CR = 41a 3 il/3kBT (12)
where kB is the Boltzman constant, changes in TR could be effected either by manipulat-
ing the viscosity (T) or temperature (T) of the system, or by changing the effective radius
(a) of the contrast agent. MRI contrast changes due to changes in the IR of a T agent are
sometimes dramatic, and sensors involving changes in TR may be particularly valuable for
dynamic imaging at today's most common clinical scanner field strengths (< 3 T).
Sherry and colleagues followed these principles and designed a paramagnetic pep-
tide (Gd"+-G80BP) that senses its protein target (Gal80) by binding to it (27); a related,
but enzyme-dependent approach was taken in a study by Aime et al. (11). In the
Gal8O/Gd3*-G80BP case, association produces a roughly 25-fold increase in TR, corre-
sponding to the ratio of Gal80-complexed to free peptide molecular sizes (here assuming
equal density). At 0.5 T, the binding reaction produced a Ti relaxivity change from 8.3
mM-1 s-1 to 44.8 mM-1 s- . Protein-protein association rates tend to be on the order of 106
M-1 s~1 (28, 29), meaning that a high-affinity binding reaction initiated by 10 pM concen-
trations of dissociated species might approach its equilibrium with a characteristic time
on the order of 0.1-1 s. Dissociation rates for this type of interaction vary widely, but
will be slower for complexes with K4 << 10-5. Because these time scales are on the order
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of typical Ti-weighted MRI TR values, sensors based on protein binding-induced
changes in TR may often, but not always, respond with rates that are limiting for the tem-
poral resolution of a dynamic MRI experiment.
Dynamic imaging with SPIO aggregation-based T2 agents
SPIO aggregation sensors. Several types of T2 relaxation-promoting smart con-
trast agents have been produced. Of these, agents based on the aggregation of biocom-
patible SPIO nanoparticles demonstrate the largest relaxivity changes, and appear to be
easily tailored to a variety of applications (30). Superparamagnetic sensors are formed by
functionalizing the surfaces of SPIOs with molecules (usually biomolecules, i.e. proteins
or nucleic acids) that associate with complementary groups on other SPIOs, either when
activated in some way, or when bridged by a particular target molecule of interest. Be-
cause the particles are multivalent, this binding or bridging induces formation of aggre-
gates, somewhat similar to the process of immunoprecipitation. Aggregation can dra-
matically amplify the transverse relaxivity of SPIOs, significantly reducing the T2 relax-
ivity even of very dilute SPIO suspensions (< 10 mg/L Fe). Ralph Weissleder and col-
leagues pioneered this approach and have applied it to make MRI sensors for specific
oligonucleotides, protease and nuclease activity, and protein-protein binding, including
antibody/epitope recognition (16, 31 and 32). Our group has adapted the approach to
construct an SPIO bioconjugate sensor for calcium (33).
The strong T2 effects produced by SPIO sensors make these contrast agents poten-
tially attractive tools for dynamic MRI studies in vivo. Little is currently known, how-
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ever, about the response dynamics of aggregation-based sensors. Most of the existing
SPIO sensors appear to respond to their targets on a several-minute time scale, though
some enzyme-dependent variants are slower. It is currently unknown to what extent de-
sign characteristics of the sensors affect rates of aggregation and concomitant relaxivity
changes. Given the relative absence of experimental data related to biofunctionalized
nanoparticle aggregation kinetics, we here explore theoretical determinants of SPIO ag-
gregation dynamics in some detail through computational modeling, with the goal of
identifying key parameters affecting the time courses and extents of aggregate formation.
In addition, we apply a rudimentary approach to approximating changes in T2 relaxivity
produced by SPIO aggregates; this allows us to convert calculated aggregation times into
estimated MRI signal changes.
Model of SPIO aggregation behavior. To model physiologically-induced SPIO
aggregation dynamics, we considered the following reaction scheme:
actiion aggreg. E, C(i. j)A;* B;*
A + B A* + 13* 1) (15)
where A and B denote two types of bioconjugated SPIO nanoparticles with different
functional groups. Under resting or baseline conditions, the groups on A and B particles
have minimal binding affinity for one another. When one or both of the two types of
functional groups are activated (converting A to A* and B to B*), their binding affinity
increases, initiating the process of particle aggregation. The end-product of the aggrega-
tion is a distribution of clusters [denoted by the summation ratio on the right hand side of
Eq. (15)] with compositions Ai*Bj* and concentrations C(i, j), where i is the number of
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A-type particles and j is the number of B-type particles in a given aggregate of total size i
+ j. Disaggregation can be induced by deactivating the functional groups, causing disso-
ciation at the molecular level; here we assume that dissociation need not precede deacti-
vation. For simplicity, we also assume that the activation and deactivation steps happen
much faster than aggregation and disaggregation. In many cases, this is a reasonable
approximation, given the relatively slow timescales for aggregate (dis)assembly (1-1000
seconds) compared to the time scales of potential (de)activation events (e.g. milliseconds
for Ca 2 -induced protein conformational changes). Some triggering events, like enzy-
matic proteolysis, might be much slower however, in which case the fast-activation con-
dition would be violated and the model we develop would have to be modified.
Aggregation phenomena are commonly formulated using the Smoluchowski equa-
tion (34), a general differential equation describing the formation and fragmentation of
various size aggregates. The Smoluchowski model assumes that every transition in the
system involves either the break-up of an aggregate into two smaller species, or the ag-
glomeration of two aggregates into a larger cluster:
dC~u, v) 1
dC,= - JjKagg(ijU - i,v - j)C(i,j)C(u - i,v -j)dt 2i09
i=0 j=0
-2 1:IK,,, (i, j u v-J)Qu, v)i=0 j=0(16)
i=0 j=0
+jKfag (,,v)C(u + i, v + j)
i-_0 =0
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Here, C(u, v) is the concentration of aggregates that contain u particles of type A and v
particles of type B. The coefficients Kagg and Kfrag are "kernels" for aggregation and
fragmentation-they function like rate constants, and reflect the probability that aggre-
gates of size (u, v) will be formed by or broken into clusters of all other allowed sizes.
The first term of equation (16) is the instantaneous rate at which aggregates of composi-
tion (u, v) are formed through the binding of all possible pairs of smaller aggregates.
Similarly, the second term accounts for the breakup of (u, v) clusters into all possible
smaller fragment pairs. The third term is the rate at which aggregates of composition
(u,v) bind to other clusters. The final term is the rate at which (u, v) clusters break off
from larger aggregates of size (u + i, v + j). Kagg and Kfrag were adapted from the litera-
ture (21, 22) in order to reflect the scenario in Eq. (15). As is common in other models,
our approach assumed that the aggregates are fractal (irregular at all length scales) and
non-circular (any two particles are connected through only one chain). These assump-
tions are valid for rigid particles with small (protein-sized) functional groups tightly an-
chored to the particle surface. See the Methods for further details.
In order to simulate the aggregation of SPIOs, we used Euler integration to obtain
mass-action solutions to Eq. (16). Figure 1A shows representative aggregation and dis-
aggregation time courses produced by our simulations. We depict both the mass-
averaged mean particle radius <r> (relative to an individual particle), and the mass-
averaged mean aggregate size <n> as functions of time. The corresponding steady-state
distribution (limit at infinite time) of aggregate sizes and compositions is shown in Figure
1 B. These time courses and distributions are consistent with results from previous Monte
Carlo simulations and experiments involving general reversible aggregation phenomena
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(21, 35). To facilitate the comparison of time courses for varying sets of parameters, we
defined an "apparent" aggregation time constant Tobs as the value for which [<n>(ToSs) -
<n>(O)] equals (l-l/e)[<n>(oo) - <n>(O)], where <n>(oo) is the steady state value of <n>
(as t goes to infinity), for an aggregation process initiated at t = 0.
Our simulations investigated the dependence of Toss and <n>(oo), on the total
nanoparticle concentration, the number of functional groups per particle and the concen-
tration ratio of complementary particles. The results, shown in Figure 1C, demonstrate a
generally non-linear dependence of Toss and <n>(oo) on these parameters. As concentra-
tion increases, both the rate of approach to equilibrium and the steady state size rise in a
supralinear fashion (panel Ci), as would be expected for a multi-body process. For in-
creasing number of functional groups per particle, Toss approximates an inverse exponen-
tial dependence, while <n>(oo) increases roughly linearly (panel C). As shown in panel C,
the maximal aggregation rate and size are found when the concentrations of complemen-
tary particles are equal. Overall, these results suggest that the kinetics of aggregation are
highly sensitive to the particulars of their design and deployment, with aggregation times
varying over three orders of magnitude within a feasible concentration and functionaliza-
tion range. At the higher end of this range, theoretically achievable aggregation times are
as short as several seconds.
As shown in the sample time courses of Figure 1A (gray regions), disaggregation
upon the removal of the activating physiological stimulus can occur on time scales con-
siderably faster than those seen for aggregation. However, the rate of disaggregation can
vary widely depending on the specific deactivation mechanism. For example, given an
allosteric mechanism where activation and deactivation of particle functional group(s)
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can occur in both bound and unbound states, deactivation can be expected to increase
dramatically the bimolecular dissociation rate kog (in addition to reducing kon), leading to
fast disaggregation. By contrast, if the functional group(s) can only be deactivated in the
unbound state, kog remains unchanged for bound particles, resulting in a much slower
disaggregation process. In general, at low nanoparticle concentrations, we expect disag-
gregation to occur faster than aggregation, making aggregation the limiting factor in the
reversible response rate of an aggregation-based sensor.
It should also be noted that the rates of aggregation and disaggregation in biological
tissues (e.g. cell cytoplasms) may be significantly slower than the rate observed in solu-
tion (36). Experiments have shown that molecular crowding in the cellular milieu re-
duces the effective diffusivity of solutes in a size-dependent manner, decreasing it by
roughly a factor of four for most biological molecules, and by a factor of 40 or more for
particles with diameters above a 50-80 nm threshold. Single SPIOs in the 30 nm size
range should fall below this threshold, but aggregates larger than a certain size will be
above it. Since under many conditions monomers are the single most common species in
the aggregation reaction, it may be possible to roughly approximate the slowing of aggre-
gation in the cellular environment by dividing the Brownian diffusivity constant by
around a factor of four (here we assumed that diffusion of each aggregate was determined
by the Stokes-Einstein equation only).
SPIO aggregation-induced changes in relaxivity. The model developed above
makes predictions about the dependence of SPIO aggregation rate on various parameters
of MRI sensors; aggregation time constants are likely to vary from several seconds to
many minutes, depending on concentration, functionalization, monomer ratio, and, in
125
biological environments, size. But how is the aggregation rate of these particles likely to
translate into MRI-observable signal changes? Although strong changes in T2 relaxivity
upon aggregation of SPIOs have been reported, little work has been done to explain the
mechanism of aggregation-induced contrast change. Previous theoretical analyses,
Monte Carlo simulations, and experimental work have shown that the T2 relaxivity of
iron oxide nanoparticles is well-described by the motional averaging approximation when
mean Larmor frequency shift at the particle surface (Ao) and the time constant for water
diffusion around the particle (Td) satisfy the condition TdAo < 1 (37, 38). This condition
is fulfilled for uncoated iron oxide crystals smaller than approximately 30 nm. For
coated SPIOs such as MION-46 (39), which contains a crystalline core of around 5 nm
diameter surrounded by an organic shell of roughly 10 nm thickness, this maximum size
for motional averaging is relaxed to around 350 nm, due to a lower field strength at the
particles' water-accessible outer surfaces.
In the motional averaging regime, outer sphere theory predicts the component of T2
relaxation due to a suspension of field-perturbing SPIO particles to be given by:
1 /T2sro =(4 /9)V(Aw0)2 r, (17)
where V is the volume fraction of solution occupied by the particles, 'cd is defined as
r= - r 2 /D, where r is the particle radius and D is the self-diffusion coefficient of water,
and Ao is given by Aco = (1/3)uoyM, where M is the particle magnetization, pio is the free
space magnetic permeability, and y is the proton gyromagnetic ratio.
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For aggregate sizes below the motional averaging cutoff, Eq. (17) and the definition
of Td predict an increase in relaxivity proportional to the square of aggregate radius. For
fractal aggregates, the relationship between the number of particles in the aggregate (n)
and its radius of gyration (r) is:
r oc n" II(18)
where df is the aggregate's fractal dimension. Typically, df is between 1.75 and 2.3 in
fractal aggregates (40, 41), with reaction-limited aggregation (see above) resulting in
larger df.
In addition, Eq. (17) and the definition of Awo predict a quadratic dependence of
relaxivity on particle magnetization, M. At field strengths above 1 T, SPIO magnetic
moments are known to be saturated (39). Under these conditions, M is field-independent
and roughly proportional to p, the density (number of particles within the volume defined
by r) of a given aggregate:
13
Macpoc n oc rr-3 oc n df (19)
r
Because V and D are independent of aggregation state, we can combine Eqs. (17-19) to
obtain a set of proportionalities:
2-
1/T2SPIO 2 r2 2df-4 nf (20)
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Since at (typical) low SPIO volume fractions 1/T2s5Po is approximately equal to R2 times
the particle concentration [cf. Eq. (14)], Eq. (20) predicts an increase in T2 relaxivity with
increasing aggregate size when the fractal dimension is greater than 2. In the limiting
case where aggregates are composed of fully-packed spherical particles (df = 3) the pro-
portionality reduces to an r2 dependence.
We simulated fractal aggregates with df = 2.2, which is on the high end of the reac-
tion-limited aggregation regime. This choice of df is somewhat arbitrary, and one would
expect the fractal dimension to vary considerably depending on the details of particle
geometry and functionalization. Although variation of df within the typical range would
have a large effect on predicted relaxivity, our simulations demonstrated that it had a neg-
ligible effect on kinetics (data not shown). For aggregates with df = 2.2, relation (20)
predicts a relaxivity proportional to n2/11. In order to characterize the relaxivity of a given
population of aggregates, we therefore calculated the mass average of n2 "11 and scaled it
by the known single-particle relaxivity.
Figure 2A shows the temporal evolution of relative relaxivity (normalized by the
unaggregated particle relaxivity) and corresponding percent change in MRI signal inten-
sity during the SPIO aggregation and disaggregation time courses shown in Figure 1A.
Signal intensity was calculated by assuming a baseline T2 for the medium of 100 ms and
setting the TE to the T2 observed in the presence of non-aggregated SPIOs. Figure 2B
shows the predicted apparent time constant (Toss, defined as above) of the change in MRI
signal intensity, along with the maximal steady-state signal change, as a function of parti-
cle concentration. These results suggest that single-second temporal resolution may be
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possible for aggregation sensors with particle concentrations in the 20-100 nM range, but
that lower SPIO concentrations will lead to considerably slower response rates. From a
practical standpoint, it is also useful to know how long it takes the aggregation-induced
signal change to reach a minimal detection threshold. We defined T5% to be the time it
takes to obtain a 5% change in signal, during aggregation of initially fully disaggregated
particles. Figure 2B shows that at high concentrations, T5% is predicted to be of order 0.1
s, but that at lower concentrations, where 5% is close to the maximal signal change, T5%
is close to 100 s, and actually longer than Tobs.
Comparison of dynamic molecular MRI methods
A conclusion from this comparison is that the fastest MRI molecular imaging tem-
poral resolution (~100 ms) is likely to be obtained with T1 agents, while the lowest con-
centrations (and greatest signal changes) may be reached with SPIO aggregation sensors.
Several caveats apply: First, most of our arguments have relied on simulations or calcu-
lations performed under idealizing assumptions; some of the findings (especially the ag-
gregation simulations) await empirical validation and may incompletely account for real-
istic experimental conditions. Second, the discussion has focused on time dependence
largely to the exclusion of other factors related to the contrast agents. In an actual dy-
namic MRI experiment, some agents with inferior "theoretical" time resolution may in
fact be preferable for unrelated reasons. Third and last, we have not attempted a compre-
hensive discussion of all existing or putative smart contrast agents and mechanisms-the
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specific agents we have addressed were chosen because they are representative or of par-
ticular interest.
Although few such experiments have been reported to date, time-resolved molecu-
lar imaging of biologically significant targets (particularly in neuroscience and develop-
mental biology) is clearly an urgent direction in MRI methods development. Quantitative
description of contrast agent properties will help direct both the selection of viable ex-
perimental strategies, and the design of new smart contrast agents with improved charac-
teristics. Our discussion suggests that high CNR is the most important requirement for
optimizing temporal resolution with T, agents, where the sensitivity of the MRI methods
currently limits acquisition rates. The development of T2 SPIO agents with enhanced
kinetic properties is also clearly recommended, given the low concentrations at which
these agents can be used; improved SPIO-based sensors could be produced by maximiz-
ing nanoparticle functionalization levels, or by loosely tethering particles to one another
in order to speed aggregation.
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FIGURES
Figure 1. Predicted characteristics of nanoparticle aggregation and disaggregation.
(A) The temporal evolution of mass-weighted average aggregate size <n>(t) (top) and
radius of gyration relative to monomer (bottom) during aggregation and disaggregation.
(B) The steady state aggregate size distribution corresponding to t = 250 s in (A). The
insert shows the composition distribution of the aggregates, with the number of type A
and type B particles on the horizontal and vertical axes, respectively. (C) Apparent ag-
gregation time constant Tobs (circles) and steady-state mass-weighted average aggregate
size <n>( oc) (squares) for a range of initial monomer concentrations (i), functionalization
densities (functional groups per particle) (ii), and concentration ratios between the com-
plementary particle types (iii). Simulation parameters are listed in the Methods section.
Figure 2. Relaxivity changes during SPIO aggregation and disaggregation. (A) The
temporal evolution of percent MRI signal change (top) and ratio of net T2 relaxivity, rela-
tive to unaggregated monomer solution (bottom), corresponding to the aggregation time
course shown in Figure 1A. (B) Apparent signal change time constant Toss (filled cir-
cles), time to reach a 5% signal change T5% (filled squares), and the steady-state percent
signal decrease (hollow diamonds), as a function of initial monomer concentration.
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